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Abstract 
Objective: To evaluate the short-term and long-term efficacy of Pulmonary 
Rehabilitation Program (PRP) in elderly subjects with C O P D living in residential 
homes in Hong Kong. 
Methods: A prospective, controlled, clinical study in elderly patients with stable 
C O P D in 25 residential homes in Hong Kong, meeting the following inclusion criteria: 
stable C O P D with <0.70 FEV,/FVC by spirometric pre- and post-bronchodilator test, 
absence of other medical or physical conditions that might limit exercise tolerance or 
cognitive functioning, and not current smokers. Patients were allocated to exercise or 
control group. All had their medications optimized initially. The exercise group 
participated in a program consisting regularly scheduled activities that included 
breathing training, graded free weights raising by arm raising, graded stepping 
exercise，and education of coordinated breathing in activities of daily living task and 
symptom management, all of which were conducted in a 12 weeks' training course in 
the residential homes, supervised by one staff in each nursing home, and reviewed 
with upgrading of exercise by the author biweekly. The control group was advised to 
have regular exercise unsupervised. Outcome measures at 0,12, and 48 weeks included 
demographic factors, respiratory fiinction (FEV„ FVC, PEFR), exercise tolerance 
tests (6-minute walking test, steps walking test, and bicycle ergometry )，and a series 
viii 
of quality of life questionnaires (Geriatric Depression Scale, the St. George's 
Respiratory Questionnaire, others). Difference between baseline and last available 
follow-up measure of outcomes were compared between and within the exercise and 
the control groups. 
Results: Of 185 screened subjects, 75 were eligible to participate, with 64 completing 
the 12 weeks' rehabilitation program, and 55 completing the last 48 weeks' follow-up. 
Baseline demographics and pulmonary function profiles were similar between the two 
groups. The mean age was 81 years; approximately half were men and half were 
women. The exercise group had a worse condition than the control group, with 
significant difference in METs and the St. George's Respiratory Questionnaire 
(SGRQ). After rehabilitation (short -term efficacy), the exercise group showed a 
statistically significantly increase in steps walking test (p=0.002) and S G R Q (p二0.01) 
compared with the control group. The exercise group also showed a larger increase in 
6 M W T (from 249.5 to 275.7 meters), while that in the control group decreased from 
247.3 to 231.2 meters. After 48 weeks (long-term efficacy), there were no differences 
between the two groups. The trend with time in the exercise group was towards 
improvement followed by decline on stopping the program, while the control group 
had a pattern of stepwise deterioration. 
Conclusion: we conclude that this Domiciliary Pulmonary Rehabilitation Program 
X 
targeted at institutionalized elderly with C O P D living in residential homes is feasible 
and effective. There is substantial evidence that the short-term PRP improving 
exercise tolerance and quality of life, but there is a trend of deteriorating Q O L and 
exercise tolerance on discontinuation of PRP. Not only community-living subjects, but 
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With improvement in environmental hygiene, advancement in medical 
technology and life saving procedures, there is a trend of increasing life expectancy 
worldwide. As a result, the prevalence of chronic diseases has also risen, together with 
disability. Chronic Obstructive Pulmonary Disease (COPD) is one of the common 
chronic diseases showing an increased prevalence. So far, the medical management of 
the disease is far from satisfactory. The only few treatment consists of cessation of 
smoking, B2 agonists, anticholinergics, corticosteroids, and long-term oxygen therapy 
(LTOT). However, the aims of treatment are preventing deterioration or complications, 
and symptomatic relief only. The condition is otherwise irreversible and patients with 
the disease suffer from variable degrees of disability. In the past ten years or so，there 
has been increasing interest in pulmonary rehabilitation program (PRP) to this group 
of patients. In this thesis, the epidemiology of C O P D , the impact of the disease 
towards patients, components and regime of pulmonary rehabilitation program and 
their efficacy will be reviewed. The result of a prospective, controlled clinical trial on a 
pulmonary rehabilitation program for elderly people residing at nursing homes will be 
described. 
1.1 Definition 
Chronic Obstructive Pulmonary Disease (COPD) is a clinical syndrome rather 
than a disease entity. The term was first introduced about 30 years ago to describe 
individuals with largely irreversible airway obstruction due to varying (but 
unspecified) combinations of intrinsic disease of the airways and emphysema. The key 
word in the syndrome is obstruction (Pride N B and Stockley RA,1996). Among 
clinicians, the disorders of chromic bronchitis, emphysema, and asthma may overlap, 
and it has been difficult to give each one a adequate definition based on a unified 
clinical, physiological, or pathological criteria (Figure 1.1；. There are diverse labels 
and definitions for C O P D between physician and epidemiologists. For 
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epidemiological purpose, we take reference with the World Health Organization 
coding for C O P D and its related diseases (ICD codes 490 - 496) The other correlated 
definitions are presented in Table (l.l).(Samet JM. 1989) 
Table 1.1 Definitions of Specific Chronic Lung Disease 
Disease ICD-9 Definition 
Code 
Chronic bronchitis 490-491 Excessive tracheobronchial mucus production 
associated with narrowing of the bronchial airways 
and cough 
Chronic obstructive 491.2 Same as chronic bronchitis with involvement of 
bronchitis smaller airways; associated with airflow 
abnormalities 
Emphysema 492 Alveolar destruction and associated airspace 
enlargement 
Asthma 493 Reversible airway obstruction with airway 
inflammation and increased airways responsiveness 
to a variety of stimuli 
Bronchiectasis 494 Destruction of bronchial wall 
Allergic alveolitis 495 Immunologically induced inflammation of the lung 
parenchyma 
Chronic airway 496 Generalized airway obstruction not classifiable as 
obstruction chronic bronchitis or chronic obstructive bronchitis 
Other externally 500-504 Dust-, fume-, or mist-induced pneumoconiosis or 




Figure 1.1 Schema of chronic obstructive pulmonary disease(COPD) 
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Note: C O P D includes patients with chronic bronchitis and emphysema and a subset of 
patients with chronic incompletely reversible asthma. Patients with C O P D outside the 
box for airways obstruction would have clinical or radiographic features of chronic 
bronchitis or emphysema. (Snider, 1988) 
1.2 Disease Prevalence 
Although C O P D is a world-wide disease and become increasingly 
important cause of morbidity and mortality(ACCP/AACVPR Pulmonary 
Rehabilitation Guidelines Panel, 1997), there are few epidemiological 
information available for many countries. In this section, the disease prevalence in 
the United States and Hong Kong will be described. 
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1.2.1 Prevalence in the United States 
In the United States, the overall prevalence of C O P D in adult white population is 
4-6% in men and 1-3% in women. In persons older than 55 years, C O P D is recognized 
in approximately 10-15%.(Higgins M W ; T h o m T 1989 ; Feinleib M , et al,1989). The 
1993 National Health Interview Survey estimates that 14 million adults had chronic 
bronchitis and 2 million had emphysema.(National Center for Health Statistics, 1993) 
In 1985, there were 17.5 million visits were made to doctors offices for C O P D 
and allied conditions that were listed as the principal diagnosis in the United States. 
There were in addition several million office visits in which these conditions were 
listed as the second or third diagnosis. (Feinleib, 1987). 
In 1989，there were 704,000 hospital discharges for which C O P D were recorded 
as the primary cause of hospitalization(Detailed Diagnoses and Surgical Procedures 
for Patients Discharged from Short-stay HospitalslUnited States, 1989) 
The numbers of deaths attibuted to C O P D in 1996 are shown in table 1.2. These 
deaths ranked the fourth among causes of death in the United States. 
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Table 1.2 Ten Leading Causes of Death in the United States 1996 
All cause 1,871,353 
J Heart Disease 733,834 
2 Cancer 544,278 
_3 Stroke 160,431 
4 Chronic Obstructive Pulmonary Disease 106,146 
_5 Accidents 93,874 
6 Pneumonia/influenza 82,579 
1_ Diabetes 61,559 
_8 HIV/AIDS 32,655 
_9 Suicide 30,862 
10 Chronic Liver Disease and Cirrhosis 25,135 
Source: Monthly Vital Statistics Report, Vol.46. 
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1.2.2 Prevalence in Hong Kong 
In Hong Kong, there is no central registry for patients with C O P D . But from the 
Hospital Authority Statistical Report ,in 1996，Respiratory system(ICD/9 460-519) is 
the third leading cause of death, occupying 20.7% of all causes of death, after 
Neoplasms (31.9%),and Circulatory system(26.1). 
The impact of C O P D on morbidity is great in Hong Kong. In 1996, there were 
95,752 patient visiting the Hospital Authority(HA)system because of respiratory 
symptoms; there were 37,366 patients discharges and deaths in H A hospital with the 
diagnosis of COPD.(Hospital Authority Statistical Report 1996/97). 
1.2.3. High- risk groups 
In the United States, death rate by age, sex, and race for C O P D are shown in 
figure 1.2. Death rates vary by age group, beginning at ages 45-54 years and increase 
sharply with increase age, especially among white men, the rate at ages 75-84 years is 
60 times that at age 45-54 years. 
Death rates are higher in men than women. The male to female ratio is 2.1. 
However, differences between the prevalence of smoking in men and women and the 
age at which they started smoking explain much of the difference in both death rate 
and prevalence. 
Also, death rates is associated with race. White-to-black ratio mortality for C O P D 
is 1.4 for age-adjusted rates. 
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Figure 1.2 Death rates for C O P D by age, sex and race in the United States in 1988 
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Source: Vital Statistics of the United States, 1988, Vol. 2, Mortality, Part A Hyattsville， 
M D : National Center for Health Statistics; 1990. U S Department of Health and 
Human Services publication (PHS) 90-110,pp 490-492, 494-496) 
In Hong Kong, mortality for respiratory system (ICD/9 460-519) is also varies 
with age, In 1996，death rate for respiratory system in all ages is 20.7%, but among the 
65 years and over group, it increase to 25.1%. (Hospital Authority Statistical Report 
1996/97). 
1.2.4. Time Trends in morbidity and mortality from COPD 
In the United States, the death rate overall C O P D have increased dramatically in 
recent years. Between 1968 and 1986，the age-adjusted death rates for coronary heart 
disease and stroke declined by 45%and 58%, respectively, whereas the death rate for 
C O P D increased by 71%.(Figiire 1.3).(Jonathan M . Samet 1989) 
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Fig. 1.3 Time trends in morbidity and mortality from C O P D 
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1.2.5. Risk Factors 
The strongest risk factor for C O P D development is cigarette smoking. Current 
Cigarette smokers show an approximate 10-fold relative risk for C O P D occurrence. 
Almost 90% of C O P D is attributable to cigarette smoking. (The Health Consequences 
of Smoking, 1984) 
Environment agents, including air pollutants, occupational dusts and chemicals, 
may contribute to C O P D incidence, either independently or in an additive fashion with 
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cigarette smoking. Several analyses from cities with high air pollution levels indicate 
that hospital admissions and mortality due to C O P D are associated with the presence 
of acidic aerosols.(Bates DV, Sizto R. 1987). 
In Hong Kong, The General Household Survey conducted in 1996 revealed that 
267 males and 31 females per 1000 persons of the respective sex above the age of 15 
were daily smokers. A continuous drop in overall smoking prevalence was noted. Yet, 
a rising trend was observed in women, except for those aged 60 and above. The rate of 
smoking among females increased from 2.7% to 3.1% compared with 1993.(Annual 
Departmental Report 1996-1997) 
1.3 Associated disability 
Chronic Obstructive Pulmonary Disease is not only a leading cause of morbidity 
and mortality in the modem world, but also the fourth largest cause of major activity 
limitation (TL, 1979). Many C O P D patients had to limit their daily activity due to their 
lung disease. They frequently have to change jobs or retire early. The social interaction 
is also adversely affected because they cannot maintain pace with their peers. This is 
the relationship between dysfunction of organ(Impairment), dysfunction of individual 
daily living(Disability), and dysfunction of social life(Handicap). In this section, we 
focus on the associated disability of C O P D in physical and psychological area. 
1.3.1 Physiological impairment 
The majority of patients with C O P D decrease in their ability to perform physical 
tasks. Fifty present of patients have activity limitation, and twenty-five present are 
bed-disable.(Higgins ITT. 1988). In 1983, C O P D and allied conditions were estimated 
to cause 130 million days of restricted activity, 72 million days of bed rest, and 7 
million days of lost work.(National Center for Health Statistics, 1986b). 
The potential pathophysiologic mechanisms that limit exercise tolerance 
inpatients with C O P D are (1) diminished ventilatory capacity,(2) hypoxemia,(3) 
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respiratory muscle dysfunction, and (4) right ventricular dysfunction secondary to 
pulmonary hypertension. Patients usually stop activities because of the intensity of 
symptoms. For example, short of breath and/or leg discomfort. But seldom activity 
may increase the muscle dysfunction, which incapacitates the patient in a vicious 
downward spiral. Values for FEVj, maximal voluntary ventilation, and maximal 
inspiratory pressure , which reflect reduced physiologic function, are important 
predictor variables for exercise performance in patients with C O P D . Unfortunately, 
FEVi decreases by 60 ml per year in C O P D patients. The rate is twice that of normals. 
Exertional dyspnea occurs when FEVj is less than 1500 ml. (John R. Bach, 1994). 
Stewart and colleagues, using the Medical Outcome Study (MOS), showed that 
patients with C O P D had decreased health-related quality of life (HRQL) in all five 
domains of the M O S : physical functioning, role functioning, social functioning, 
mental health, health perceptions, and bodily pain.(Stewart,al et，1989). Furthermore, 
patients with C O P D consistently scored worse on all domains than patients with 
hypertension, arthritis, and diabetes, and worse than those with chronic back pain on 
all domains except bodily pain. 
1.3.2 Psychological impairment 
In a study of a group of patients with severe COPD, McSweeny and associates 
noted that patients with C O P D experience negative changes in mood and social 
behavior that include depression, anxiety, irritability, and paranoia. Depression 
seemed to be the most preponderant emotional disturbance noted. McSweeny and 
associates reported that the prevalence of depression in patients with severe C O P D is 
42%(McSweeny,et al 1882); Light and colleagues used a Beck Depression Inventory 
found the same prevalence in a group of patients with less severe COPD.(Light R W , et 
al, 1985). Other studies have also reported that patients with C O P D tend to be 
depressed. (Kass I, et al, 1975; Morgan A D , et al, 1983; Rutter B M , 1977). Fairly high 
levels of fatigue and anxiety were noted by patients and corroborated by their relatives. 
Also observed was impairment of psychological resiliency. In contrast to previous 
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studies, patients did not report unusual degrees of suspicion and anger. 
What is the relationship with physiological measurements , emotional 
dysfunction, and health-related quality of life(HRQL)? In general, summary statistics 
of correlation from different studies should be compared with caution, since studies 
have different entry criteria, measure different outcome measures, and use different 
statistical techniques. Nevertheless the squared correlation coefficients (R2) between 
different variables in H R Q L studies have shown some homogeneity. In J Randall 
Curtis' s study, the correlation is shown in Fig,4 (Panel A and Panel B.) 
H R Q L and the dyspnea scale correlate better with one another than the 
physiological parameters and descriptive variables. Depression and anxiety have an 
intermediate correlation with H R Q L and the dyspnoea scale. 
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Fig 1.4-a Correlation of H R Q L with dyspnoea, pulmonary function oxygenation, 
and exercise tolerance 
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* Panel A shows the correlation of H R Q L and dyspnoea with each other and 
with measures of pulmonary function, oxygenation, and exercise 
tolerance 
* Panel B shows the correlation of H R Q L with psychological states and 
demographic variables 
It is interesting that there was no significant relationship between 
emotional dysfunction and physical measurement.(Richard W , et al,1985) 
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1.4 Treatment - effectiveness 
1.4.1 Goals of management 
Management for C O P D is often unsatisfactory and there are no currently 
available drug treatments that influence its progressive course (Peter JB, 1998). Most 
current C O P D guidelines, include The Canadian Thoracic Society (CTS)，The 
European Respiratory Society (ERS)，The American Thoracic Society (ATS), The 
Thoracic Society of Australia and N e w Zealand , and The British Thoracic Society 
(BTS), have a consensus that the main aim of C O P D management is to achieve and 
maintain control of the disease. This includes improving symptoms and quality of life 
and reducing C O P D exacerbation; to improving lung function and reducing the 
accelerated decline in lung function; preventing and effectively treating complications; 
reducing mortality; and avoiding or minimizing treatment side effects. (Canadian 
Thoracic Society Workshop Group, 1992; Siafakas N M , et al, 1995; Jenkins C, et al, 
1995; Celli BR, et al, 1995; The C O P D Guidelines Group of the Standards of Care 
Committee of the British Thoracic Society，1997). 
1.4.2 Smoking cessation and Long-term oxygen therapy (LTOT) 
All C O P D guidelines consistently state that smoking cessation and long term 
oxygen therapy (LTOT) are the only two available treatment options have been proved 
to achieve the aim of treatment. (Leonardo F, 1998). 
In young smokers with minor airways obstruction there maybe an improvement 
in FEVi on stopping smoking; in middle age, the major effect is to slow subsequent 
decline in FEV,, nearly to that of healthy never smokers. In advanced C O P D it is less 
certain that further decline in FEV! is slowed, so that it is important to stopping 
smoking at earlier stages of the disease. (Pride N B , Stockley RA, 1996). Smoking 
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cessation consistently results in a reduction in cough, expectoration, and acute 
respiratory infections. But not improvement in breathlessness, since the lost function 
cannot be restored. Smoking cessation will deteriorate more slowly and have a better 
chance of benefiting from treatment such as LTOT. (Cooper CB, 1995) 
There are two famous trials of long term oxygen therapy in patients with C O P D 
and chronic, stable hypoxemia. One is Nocturnal Oxygen Therapy Trial (NOTT) 
(Nocturnal Oxygen Therapy Trial Group, 1980), which compare nocturnal 
treatment(about 12h/d) with continuous treatment(about 19h/d). Another trial is 
British Medical Research Council (MRC)-sponsored trial (Medical Research Council 
Working Party, 1981), that compared 15h/d of oxygen therapy with none at all. Both 
showed the benefits of oxygen therapy as below: 
• Improved survival --- In the M R C study five year survival improve from 25% 
to 41% with 15 hours of oxygen therapy per day; In Cooper CB's study, 
survival improved to 62% at five years, but was only 26% at 10 years (Cooper 
CB, et al，1987). The long-term survival in patients with C O P D on LTOT is 
inversely related to the FEVj. 
• Less secondary polycythemia; 
• Prevention of progression of pulmonary hypertension; 
• An improvement in neuropsychological health. 
However, the role of oxygen therapy has not been well worked out in episodic 
hypoxemia, such as that occurring during sleep and exercise (Robert M . et al,1998). 
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1.4.3 Pharmacologic treatment 
1.4.3.1 Pharmacologic treatment of stable disease 
In all current guidelines there is a consensus that the bronchodilators are the 
cornerstone of the pharmacologic treatment of stable C O P D . (Canadian Thoracic 
Society Workshop Group, 1992; Siafakas N M , et al, 1995; Jenkins C，et al, 1995; Celli 
BR, et al, 1995; The C O P D Guidelines Group of the Standards of Care Committee of 
the British Thoracic Society, 1997). They probably act by reducing bronchomotor tone 
and hence airway resistance in patients with C O P D and by reducing the level of 
pulmonary overinflation. (Gross NJ. et al. 1989;Gross NJ. et al. 1984). 
However, no clear consensus is present in the current C O P D guidelines on 
which is the first choice of bronchodilators. The ERS and BTS guidelines recommend 
in mild disease one short-acting B2 agonist or an inhaled anticholinergic agent as 
needed, depending on symptomatic response (Siafakas N M , et al, 1995; The C O P D 
Guidelines Group of the Standards of Care Committee of the British Thoracic 
Society, 1997). The ATS guideline recommend one short-acting B2 agonist as 
needed.( Celli BR, et al, 1995). In more advanced COPD, current guidelines 
recommend regular therapy with one short-acting B2 agonist, an inhaled 
anticholinergic agent, or a combination of the two. If ineffective, the addition of other 
bronchodilators, such as theophylline should be considered. (Canadian Thoracic 
Society Workshop Group, 1992; Siafakas N M , et al, 1995; Jenkins C, et al, 1995; Celli 
BR, et al, 1995; The C O P D Guidelines Group of the Standards of Care Committee of 
the British Thoracic Society, 1997). In addition, the inhaler technique is important. A 
recent study showed that 76% of patients with C O P D made important errors when 
using their metered does inhaler whilst 10-40% made similar errors with a dry powder 
inhaler, depending on the devices used. (Van der PJ, et al, 1995) 
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The role of many others drugs in stable C O P D require further study. These 
include inhaled glucocorticoids, mucolytic drugs, and other anti-inflammatory drugs. 
On present evidences, inhaled steroids should be given to patients who show an 
objective response to corticosteroids, either oral or inhaled. Patients with substantial 
responses to an oral steroid trial justify treatment according to the guidelines on the 
management of chronic asthma. (BTS, 1997). Those who do not respond should not 
continue on steroid therapy. 
1.4.3.2 Pharmacologic treatment of exacerbations 
The treatment of asthma exacerbations is reasonably standardized, but is much 
less established of C O P D exacerbations, probably because of the limited number of 
properly conducted studies that have been performed. In fact, the treatment of asthma 
and C O P D exacerbations is similar, i.e., based on the administration of oxygen， 
short-acting bronchodilators, and systemic glucocorticoids, although there is no firm 
recommendation for the use of systemic glucocorticoids. (Canadian Thoracic Society 
Workshop Group, 1992; Siafakas N M , et al, 1995; Jenkins C，et al, 1995; Celli BR, et 
al, 1995; The C O P D Guidelines Group of the Standards of Care Committee of the 
British Thoracic Society, 1997). 
Antibiotics are recommended in all current guidelines and are almost always 
used in general practice in treatment of C O P D excerbations, based on the erroneous 
rationale that exacerbations are often due to lower airways bacterial infection. 
1.4.4 Nonpharmacologic treatment 
1.4.4.1 Rehabilitation 
Most guidelines showed the benefits of Pulmonary Rehabilitation in patients 
with C O P D improve exercise capacity and quality of life. (Canadian Thoracic Society 
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Workshop Group, 1992; Siafakas N M , et al, 1995; Jenkins C, et al, 1995; Celli BR, ct 
al, 1995; The C O P D Guidelines Group of the Standards of Care Committee of the 
British Thoracic Society, 1997). In next section, the regime of pulmonary 
rehabilitation program and their efficacy will be reviewed. 
1.4.4.2 Vaccination 
All C O P D guidelines recommend yearly influenza vaccination; Elderly patients 
(but not specifically having COPD) have been shown to have a 70% reduction in 
mortality from influenza following vaccination (Kilboume ED, 1988). This implies 
that vaccination in severe C O P D is likely to be effective. However, further studies 
specific to mild and moderate C O P D are lacked. (American College of Physicians 
Task Force on Adult Immunization, 1990). 
1.4.4.3 Nutrition 
Malnutrition is common in patients with severe C O P D and may contribute to 
mortality.(Hunter A B N , et al, 1985; Fitting JW, 1992). Overweight will enlarge the 
energy requirement of exercise and increase the disability. Appropriate dietary advice 
and nutritional support should be offered. 
1.4.4.4 Surgical treatment 
Some patients with large bulla can be improved by surgical procedure such as 
hung reduction or transplantation, and can provide dramatic relief of symptoms and 
improvement in lung function for patients with advanced COPD.(Pride N B and 





Pulmonary rehabilitation was defined inl 974 by the American College of 
Chest Physicians Committee. (Petty, TL,1975). That the same definition was adopted 
in the Official American Thoracic Society statement on pulmonary rehabilitation in 
1981 (Hodgkin JE, et al, 1981): 
"Pulmonary rehabilitation may be defined as an art of medical practice wherein an 
individually tailored, multidisciplinary program is formulated which through accurate 
diagnosis, therapy, emotional support, and education, stabilizes or reverses both the 
physio- and psychopathology of pulmonary diseases and attempts to return the patient 
to the highest possible functional capacity allowed by his pulmonary handicap and 
overall life situation." 
This definition focuses on three important features of successful rehabilitation 
programs: 
1. Individual: Patients with disabling C O P D require individual assessment of 
their needs, individual attention, and a program designed to meet realistic individual 
goals. 
2. Multidisciplinary: Pulmonary rehabilitation integrates expertise from various 
health-care disciplines integrated into a comprehensive, cohesive program tailored to 
the needs of each patient. 
3. Attention to physio- and psychopathology: To be successful, pulmonary 
rehabilitation program must address psychological and emotional problems as well as 
pathophysiologic problems. 
(ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel, 1997) 
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In 1994, the National Institutes of Health Consensus Conference on Pulmonary 
Rehabilitation developed a newer definition to describe the process: 
“ Pulmonary rehabilitation is a multidimensional continuum of services directed 
to persons with pulmonary disease and their families, usually by an interdisciplinary 
team of specialists, with the goal of achieving and maintaining the individuals 
maximum level of independence and functioning in the community."(Fishman AP, 
1994) 
This definition emphasis key aspect as multidimensional activity, which 
suggest more numerous and disparate skills than are ordinarily trained in one therapist; 
continuum of service implies a smooth and long time melding of skills and 
disciplines to enable patients to become functional over the long term; 
interdisciplinary team suggest in pulmonary rehabilitation may include physicians, 
nurses, respiratory physician, and occupational therapists, psychologists, exercise 
specialists, dieticians, and others with appropriate expertise.(ACCP/AACVPR 
Pulmonary Rehabilitation Guidelines Panel, 1997); the program involvement of 
patients and families and individual goals for achieve maximal ability and minimal 
handicap. 
1.5.2 Aims 
Pulmonary rehabilitation is ideally a comprehensive management strategy 
addresses all components of the chronic and progressive lung disease (Tiep BL,1997). 
In a functional definition, pulmonary rehabilitation applies art, skill, physiology, and 
multiple clinical disciplines to prevent and reverse the disability associated with 
chronic lung disease. ( Tiep BL, 1993) 
To a successful pulmonary rehabilitation, the patient and therapeutic team must 
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have high but realistic aims and expectation. Patient goals need to be established and 
reviewed with the patient at the beginning of the program. It should achievable to 
improve patient motivation, adherence, and outcomes. (ACVPR, 1998). 
Typical patient goals are presented in the table 1.3: 
Table 1.3: Patient goals in pulmonary rehabilitation program. 
(AACVPR,1998; Tiep BL,1993) 
1 Feeling Better 
• Breathe better, less reduced dyspnea; 
• Decrease anxiety, depression，and panic; 
• Decrease frequent insomnia; 
• Increase confidence 
2 Greater Activity 
• At home 
• In the community 
• During leisure time 
3 Increased Strength and Endurance 
• Muscles of ambulation 
• Upper extremities 
• Ventilatory muscles 
4 Greater Range of Function 
• Self-care 
• Care of the home 
• Shopping and/or travel 
• Sexual activity 
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• Leisure activity 
• Return to work 
5 Self-Control and Self-Management 
• Dyspnea 
• Living situation 




• Prevent exacerbation and hospitalization 
During the long process of physiologic deteration pulmonary patients live of 
progressive inactivity which forged by dyspnea and archored by the fear of dyspnea. In 
the latter stages, they have become dependent on others and have relinquished control 
of lives. Thus, the reduction of dyspnea is a major goal of pulmonary rehabilitation 
(Mahler D A , 1990). 
Moreover, pulmonary rehabilitation must optimally manage the reversible 
components of pulmonary impairment and improve patient strength, endurance, and 
stamina while attending to the myriad physiologic and psychologic factors that have 
woven the pattern of disability (Hodgkin JE, et al, 1984). 
When patients become more active and independent, they will be able to 
venture out of their homes and assume a more active role in the community. Some 
patients will even return to work. 
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1.5.3 Method 
Pulmonary rehabilitation has been appropriately considered as comprehensive 
care for patients with chronic respiratory disorders. The essential components of 
pulmonary rehabilitation are team assessment, patient training, exercise, 
psychosocial intervention, and follow-up. (AACVPR，1998). As shown in table 1.4. 
Prevention strategies should be integrated into every aspect of the program. It is an 
individualized program that meets the specific needs of each pulmonary patient. 
Although not every patient requires all of the interdisciplinary services mentioned in 
table 1.4, but these services should be available if needed. 
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Table 1.4: Essential Components of Pulmonary Rehabilitation 
1 Team *patient selection *medical history *symptom assessment 
Assessment *physical assessment * diagnostic tests *nutritional assessment 
* activities of daily living assessment *exercise assessment 
*educational assessment *psychosocial assessment 
2 Patient *learning principles *normal pulmonary anatomy and physiology 
Training *pathophysiology of lung disease * description and interpretation of 
medical tests *breathing retraining *medication *exercise 
principles *respiratory modalities * self-assessment and symptom 
management *nutrition *ethical issues .psychosocial issues 
respiratory modalities 
3 Exercise *mode, duration, frequency, and intensity * strength training 
* orthopedic limitations *flexibility and posture *upper and lower 
extremity endurance training *respiratory muscle training 
*home exercise plan 
4 *adjustment process *identification of support systems *treatment 
Psychosocial of depression *treatment of anxiety and panic ^pharmacological 
Intervention interventions * anger management * sexuality issues *development 
of adaptive coping styles *understanding role changes * adherence 
to lifestyle modifications *relapse prevention 
5 Follow-up *patient outcomes .maintenance exercise program *support groups 
* social events *pulmonary rehabilitation volunteer *program 
newsletter *post-program questionnaire r^evaluation as necessary 
26 
note: pulmonary rehabilitation should address health promotion and disease 
prevention, which can be accomplished when prevention is integrated into every 
component. Training or exercise alone does not constitute a pulmonary rehabilitation 
program. 
1.5.3.1 Team assessment: 
It is the first step in pulmonary rehabilitation, include candidates selection and 
candidates assessment. This step sets the foundation for tailoring the program to meet 
the patient's individual needs. 
• Candidates selection 
Any patient with symptomatic chronic lung disease is a candidate for pulmonary 
rehabilitation. The degree of impairment in pulmonary function testing is commonly 
used as the primary selection criteria, but it is not sufficient as selection criteria alone. 
Symptoms, especially dyspnea, correlate better with functional ability than FEV! or 
other measures of pulmonary function.(Mahler D A , and Harver A, 1990). In addition 
to the presence of disease, health-related quality of life resulting from the disease or 
its co-morbidity should be another important selection criterion. Reduction in physical 
activity, occupational performance, activities of daily living, and increases in medical 
resource consumption should be evaluated and used in the selection process. 
(American Thoracic Society, 1995). 
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Concurrent diseases or conditions that may interfere with the rehabilitation 
process or place the patient at substantial risk during exercise should be corrected or 
stabilized before the patient enters the program. Permanent or temporary conditions, 
for example, ischemic cardiac disease, congestive heart failure, acute cor pulmonale, 
severe pulmonary hypertension, Significant hepatic dysfunction, metastatic cancer, 
disabling stroke, active substance abuse, severe cognitive deficit, and severe 
psychiatric disease may be considered contraindications to pulmonary rehabilitation. 
(Beutas L and Connors GL, 1993) 
Current smoking status has been used by some programs as a consideration. 1) 
the past experience of accepting those patients who vowed to quit on the first day of 
their program is that they frequently start smoking soon after program completion; 2) 
supplemental oxygen therapy is unsafe and probable ineffective for those smoking 
patients; 3) other patients in the program maybe sensitive to and antagonized by the 
smell of smoke. Therefore, some programs only accept nonsmokers for respiratory 
rehabilitation. (Roger SG, and Monica A A , 1993) 
Age alone should not be used as a selection criterion for pulmonary 
rehabilitation. Older persons make up a large proportion of patients with obstructive 
and other chronic lung diseases and may live many years with the condition (Ries AL， 
1990) 
28 
• Candidates assessment 
The objectives of the initial assessment for respiratory rehabilitation include (1) 
confirming the diagnosis; (2) establishing and characterizing the severity of the main 
symptoms; (3) identifying the impact of the disease on the patient's lifestyle. The 
assessment may be performed by members of the interdisciplinary team, as 
determined by the patient's individualized needs. The initial assessment should include 
a patient interview and the components listed in table 1.5 Below: (AACPR, 1998) 
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Table 1.5: Component of the Initial Candidates Assessment 
Component Details 
Medical 1) Respiratory history; 2) Family history of respiratory disease; 
History 3) Active medical problems; 4) Other medical and surgical history; 
5) Utilization of medical resoiirces(e.g.,hospitalizations, urgent 
care/emergency room visits, physician visits); 6) All current 
medications including over-the counter drugs; 7) Allergies and drug 
intolerance; 8) Smoking history; 9) Occupational environmental, and 
recreational exposures; 10) alcohol and other substance abuse history 
Diagnostic 1) Spirometry pre- and postbronchodilator; 2) Lung volumes; 3) 
Tests Diffusing capacity; 4) Resting arterial blood gas; 5) Arterial oxygen 
saturation by pulse oximetry; 6) Chest radiograph; 7) Resting 
electrocardiogram; 8) Exercise test with cutaneous oximetry and/or 
arterial blood gas; 9) Complete blood count; 10) Basic blood 
chemistry panel 
Symptom 1) Dyspnea: on exertion, at rest, nocturnal; 2) Cough; 3) Sputum 
Assessment volume, color, consistency, smell; 4) Fatigue; 5) Wheeze; 6) 
Hemoptysis; 7) Chest pain; 8) Postnasal drainage; 9) Reflux, 
heartburn; 10) Edema: pedal, pretibial; 11) Dysphagia, swallowing 
problems 
Physical 1) Vital signs: height, weight, blood pressure, heart rate, respiratory 
Assessment rate, temperature; 2) Breathing pattern; 3) Use of accessory muscles 
of respiration; 4) Chest examination; 5) Signs of congestive heart 
failure; 6) Presence of finger clubbing; 7) Presence of finger 
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clubbing; 8) Arterial oxygen saturation measured with pulse oximetry 
at rest and with activity. 
Nutritional 1) Height and weight; 2) Weight change; 3) Dietary history, diet 
Assessment recall(3-7 days); 4) Person responsible for shopping and food 
preparation; 5) Fluid intake; 6) Alcohol consumption; 7) Laboratory 
tests of nutritional status; 8) Body mass index; 9) Drug/nutrient 
interactions; 10) Lean body mass determination, when indicated; 11) 
Need for nutritional supplements. 
Activities 1) Functional task performance; 2) Breathing techniques with ADLs; 
of Daily 3) Upper extremity function; 4) Energy conservation; 5) Need for 
Living adaptive equipment; 6) Food procurement and preparation; 7) Leisure 
Assessment impairment; 8) Sexual function; 9) Work environment demands. 
Educational 1) Knowledge of disease, treatment, and so forth; 2) Hearing; 3) 
Assessment Vision; 4) Cognitive ability; 5) Language; 6) Literacy; 7) Cultural 
diversity. 
Exercise 1) Physical limitation; 2) Orthopedic limitations; 3) Transferring 
Assessment abilities; 4) Exercise tolerance; 5) Exercise hypoxemia including the 
need for supplemental oxygen therapy; 6) Cardiac function; 7) 
Exercise modification 
Psycho- 1) Perception of quality of life and ability to adjust to the disease; 2) 
social Interpersonal conflict; 3) Psychopathology(e.g., depression, anxiety， 
Assessment etc.); 4) Substance abuse; 5) Neuropsychological impairment; 6) 
Sexual dysfunction; 7) Motivation for pulmonary rehabilitation 
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Assessment is one of the most critical components of the pulmonary 
rehabilitation program, a precursor to patient training, psychosocial intervention 
exercise, and follow-up. Realistic patient goals are determined during the assessment 
and reevaluated during the program as necessary. Assessment is the key to prevention 
and early detection of lung disease when intervention may prevent a disastrous 
outcome. 
1.5.3.2 Patient Training 
Following a thorough patient selection and assessment, the interdisciplinary team 
can begin to develop the necessary training session for the pulmonary rehabilitation 
patients. Achieving the goals of pulmonary rehabilitation requires that the patients, 
family members, and significant other individuals to understand the patient's disease 
and try to leam specific means to deal with problems. The patient training objectives 
should therefore encourage patients to make behavioral changes that lead to improved 
health and enable them to become active participants in their own health care (Neish 
C M , and Hopp JW，1988). The key steps in the training process include : 1) Assess the 
patient's education needs; 2) Determine how the patient leams best; 3) Select the 
training approach or style that most benefits the patient. 
The training program may consist of class, individual, and audiovisual formats. It 
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may need to be reassessed during the program. The following topics maybe include in 
the training component of the pulmonary rehabilitation program:(AACPR, 1998) 
• Normal pulmonary anatomy and physiology 
• Pathophysiology of lung disease 
• Description and interpretation of medical tests 
• Breathing retraining 
• Bronchial hygiene 
• Medications 
• Exercise principles 
• Activities of daily living and energy conservation 
• Respiratory modalities 
• Self-assessment and symptom management 
• Nutrition 
• Psychosocial issues 
• Ethical issues 
The general philosophy of the program should be to encourage patients to assume 
responsibility for and to become active participants and partners in providing their 
own care. (Moser K M , et al,. 1991) 
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1.5.3.3 Exercise 
Exercise reconditioning should be considered for all patients of chronic lung 
disease and is an important component of pulmonary rehabilitation. The benefits of 
exercise training are well documented. They include increased tolerance for dyspnea, 
improved appetite, increased physical capability, and improved quality of life. 
(ACCVPR, 1998) 
Before a safe program can be outlined, a thorough assessment needs to be done 
to evaluate exercise tolerance, formulate an appropriate exercise training prescription, 
detect exercise-induced hypoxemia, help determine the need for supplemental oxygen, 
and detect occult cardiac or other nonpulmonary limitations to exercise. 
Suggested guidelines for endurance exercise training for patients with C O P D are as 
follows: (Ries AL, 1993) 
1. Frequency: daily 
2 Intensity: 
a. Ventilatory limited(not anaerobic); symptom limit(breathlessness): 90-
100% of maximum 
b. Not ventilatory limited(anaerobic)； anaerobic threshold: 60-80% of 
maximimi(approximate) 
3 Duration: 15-30 minutes of continuous activity 
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4 Mode: many different modes of exercise have been used successfully, include 
walking, cycling, stationary bicycling, arm ergometry, arm lifting exercises 
with or without weights, step exercise, rowing, water exercises, swimming, 
modified aerobic dance, and seated aerobics. 
There are four general exercise training modalities are used: 1) upper extremity 
training; 2) lower extremity training; 3) strength training; 4) respiratory muscle 
training. The benefits and types of above four training modalities is shown in table 1.6: 
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Table 1.6 Exercise Training Modalities 
Modality Benefit Types 
Upper Improves performance for task- 1) Arm ergometry 
extremity specific arm activities such as 2) Hand weights 
training bathing, grooming, lifting, and so 3) Elastic bands 
forth.(Celli BR, 1994) 4) Wall pulleys 
5) Posture-specific exercises 
Lower Improves performance in 1) Walking 
extremity ADLs.(ACSM, 1995) 2) Stationary bike 
training 3) Bicycling 
4) Rowing 
5) Stairs 
Strength Improvement in muscle strength, 1) Hand and ankle weights 
training exercise endurance, and fewer 2) Free weights 
symptoms during ADLs.(Celli 3) Circuit resistance 
BR, 1994) 
Respiratory Increase in respiratory muscle 1) Flow resistive training 
muscle training strength and endurance as well as 2) Threshold loading 
a reduction in sensations of training 
dyspnea(Patessio A, et al, 1989) 3) Isocapneic 
hyperventilation 
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1.5.3.4 Psychosocial Intervention 
Psychosocial assessment and intervention is an essential component of 
pulmonary rehabilitation. The development of chronic pulmonary disease can have a 
marked impact on the overall quality of life for both patients and their families. 
Screening for psychosocial disorders should be conducted during the initial 
assessment, with findings integrated into the comprehensive treatment plan. 
All patient are likely to benefit from some supportive counseling addressing 
one or more areas of concem(e.g., sexuality, anxiety, social support). Interventions 
may be provided in a one-on-one or group format, depending on the intensity of 
patient distress and the availability of therapeutic resources. Counseling can be 
delivered as a focused topic( e.g.，stress management module)or during the course of 
other rehabilitative activities(e.g., during breathing retraining). As noted above, 
individuals experiencing significant emotional distress(e.g.，depression) should be 
referred for further evaluation and should be coordinated with the patient's primary 
care or mental health provider. 
1.5.3.5 Follow-up 
Pulmonary rehabilitation is an ongoing process of lifestyle changes that begins 
with the participant's entrance into the program and continues throughout the follow-
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up component.(Hodgkin JE, et al, 1993). Follow-up is needed for pulmonary 
rehabilitation graduates to continue to improve their quality of life and physical and 
functional activities.(CQI) Various types of follow-up options for their graduates is 
described below, which help to promote compliance with rehabilitation goals, 
maintain long-term benefits, and provide psychosocial support. One of the key options 
is maintenance exercise. 
• Maintenance exercise program 
• Physician's office visits 
• Keeping the primary care physician informed and updated on progress 
• Support/educational groups 
• Transplant support groups 
• Family support groups 
• Participants, phone tree 
• Social events including parties, outings, and trips 
• Newsletters 
• Volunteering with rehabilitation program 
• Referral to community groups(ALA and Better Breathers, club) 
• Phone follow-up by rehabilitation program staff 
• Post-program questionnaires 
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• Home visits by rehabilitation staff 
• Reevaluation by rehabilitation staff 
• National Pulmonary Rehabilitation Week(observed during the first week of 
spring) 
• Home health referral to home care company and/or home health agency 
• Referral to vocational rehabilitation 
(Beytas L and Connors GL，1993) 
1.5.4 Assessment of outcome 
Pulmonary rehabilitation programs can enhance the quality of life and improve 
outcomes for patients with pulmonary disease. With the health care atmosphere 
continually changing and the emphasis on quality, cost, and outcomes, it is increasingly 
important to incorporate outcome assessment into the rehabilitation program. 
( A A C V P R Outcome Tools Resource Guide. Compiled by the American Association of 
Cardiovascular and Pulmonary Rehabilitation Outcomes Committee. Updated 12/97) 
In this section, synopsis of the tools currently available for measuring 
outcomes in pulmonary rehabilitation is compiled, it depends on the A A C V P R 
outcome tools resource guide (AACVPR, 1998) 
After reviewing many areas of outcome, the American Association of 
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Cardiovascular and Pulmonary Rehabilitation (AACVPR) Outcome Committee 
suggests selecting and assessing change in each of three general areas of pulmonary 
rehabilitation patients: Health, Clinical, and Behavioral. They recommend that each 
rehabilitation program measure at least one quality of life measure, one functional 
activity or exercise-related measure, and one behavioral measure. 
• Health section 
The health section contains the quality of life tools, which divided into general 
quality of life tools, and pulmonary-specific quality of life tools; functional activity 
and exercise-related measures. The tools are presented in table 1.7: 
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Table 1.7: Health-related Tools 
Tool Name Tool measures Author(s) 
1 General Quality of Life Tools 
artmouth Functional status: physical, emotional, and Dartmouth C O O P 
Primary Care social role function, pain, overall health, Project 
Cooperative 
(COOP) health change, quality of life, and social 
Information support. 
D U K E Health Five health measures(physical, mental, George 
social, general, and perceived), a self- Parkerson, Jr. 
esteem measure, and four measures of 
dysfunction(anxiety, depression, pain, and 
disability) 
Illness Effects Biological, psychological, and social Glen Greenberg， 





Medical Health and functional status in eight areas Ware J.E. and 丨 
Outcomes under three categories:!) functional status, Sherboume C.D. 
Study Short 
YQJ^ 2) well-being, and 3) general health 
(MOS SF-36) perception 
Multidimensio Perceived control over health and health Wallston, 
nal Health „ ^ , ^  






Nottingham Quality of life including energy, pain, Sonja Hunt and 
Health emotional reaction, physical mobility, Carlos Martini 
Profile(NHP) 
sleep, social isolation, and activities of 
daily living 
Quality of L i f e T h e gap between the patient's actual Gilles Dupuis. 
Systemic condition and the goal for 30 life domains, 
Inventory 
taking into account the priority of each life 
(QLbl) 
domain and the actual dynamic process of 
evolution within each one(this represents 
the Q O L score) 
Quality of Mobility, physical activity, social activity, Kaplan R.M. 
Well-Being self-care, and symptoms 
Scale(QWB) 
Sickness Perceived health status in physical, Gibson BS, 
Impact psychological, and five independent Bergner M , 
Profile(SIP) factors Bobbitt RA, and 
I 
Carter W B ’ 
r 
Symptom Depression, anxiety, somatic symptoms, Robert Kellner. ‘ 
Questionnaire and anger-hostility 
Psychosocial Coping with illness; handicap Morrow GR, 
Adjustment to Chiarello R, and 
Illness Scale Derogatis L. 
2 Pulmonary-Special Quality of Life Tools 
Chronic Dyspnea, fatigue, emotional function, Guyatt G H , 
Respiratory mastery of disease Berman LB, 
L _ _ _ 
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Disease Townsend M , et 
Questionnaire 
(CRQ) 
Pulmonary Dyspnea and functional status in patients Suzanne C. 





Pulmonary Activities of daily living in respiratory Terri Weaver. 
Functional patients including self care, transportation, 
Status household tasks, grocery shopping, meal 
Scale(PFSS) prep, daily activities, relationships, 
dyspnea anxiety, depression 








• Clinical Section 
The clinical section contains functional activity and exercise-related measures, 
psychological measure and psychosocial measure. The tools are present in table 1.8: 
Table 1.8: Clinical Tools 
Tool name Tool measures Author(s) 
1 Physical-functional Activity and Exercise-related measures 
Baseline Dyspnea Baseline and transitional dyspneaDonald Mahler, 
Index and Weinberg DH， 
Transitional Dyspnea Wells CK，and 
Index(BDI/TDI) Feinstein A R . 
Borg Scale Severity of dyspnea on a 1-10 Guimar Borg 
category scale(with ratio properies) 
Duke Activity Status Functional Status Hlatky M , Boineau : 
Index(DASI) R, and , 
Higgenbotham M . ( 
Functional Status Physical, psychological, social, and Jette A M , Davies i 
Questionnaire role function in ambulatory A R , and Cleary PD. j 
patients , 
Graded Exercise Using treadmill or cycle ergometer -- ‘ 
Test(GXT) to measures workload, oxygen 
consumption, heart rate, 
arrhythmias, and blood pressure 
responses with exertion. 
Human Activity Activity level based on estimated Fix AJ, and 
Profile(HAP) METs Daughton D M . 
N Y H A Functional Grades limitations of ability to Harvey R, Koyle E, 
Classification perform physical activity and Ellis K. 
Six or Twelve Exercise endiirance(area of McGavin CR, 
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Minute Walk function) Gupta SP, and 
Mchardy GJR. 
Specific Activity Functional Class Goldman L, 
Scale Hashimoto B, et al 
Visual Analog Severity of dyspnea with a 100 m m Gift A G . 
Scale(VAS) vertical line during exercise 
2 Psychological Tools 
Beck Depression Depressive symptomatology Aaron Beck 
Inventory (BDI) 




C O P D Self-EfficacyConfidence level Joan Wigel, 
Scale Thomas Creer, 
Harry Kotses 
C O P E Inventory Different ways in which people Carver DS, Scheier 
respond to stress MP., and Weintraub 
SK. 
Face Scale mood Lorish C. and 
Maisiak R. 
Jenkins Activity Four common components of Type Jenkins C. 
Survey(JAS) A behavior Rosenman R., and 
Friedman M . 
Minnesota Personality functioning, including Dahlstrom W , 
Multiphasic depression, anxiety, psychosis, and Walsh G., and 
Personality personality disorders Dahlstrom L. 
Inventory(MMPI)-2 
Profile of Mood Various mood states McNair D., Lorr M.， 
States(POMS) and Droppleman L. 
Psychological Both negative and positive mood Dupuy H. 
General Well-Being states 
Index(PGWB) 
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Sixteen PersonalitySixteen different personality Raymond Cattell, 
Factor factors including emotional Karen C, and 
Questionnaire(l 6PF) stability, self-sufficiency, tension, Heather C. 
rigidity 
State Trait Anger State and trait anger Charles D. 
Expression Inventory Spielberger. 
State Trait Anxiety State anxiety and trait anxiety Spielberger C., 
Gonsuch R.，and 
Luschene R. 
Symptom Checklist-Subjective indicators of Derogatis R., Brand 
90-Revised(SCL-90- psychological well-being, R.，and Jenkins C. 
R) including depression, anxiety, 
hostility, somatization 
Ways of Coping Thoughts and actions people use to Folkman and 
Questionnaire handle stressful situations Lazarus 
3 Psychosocial Tools 
Locke-Wallace Marital adjustment Locke HJ., and 
Marital Adjustment Wallace K M . 
Test(LWMAT) 
M O S Social Support Four dimensions of social support: Sherboume C. and 
Survey emotional /informational, tangible, Stewart A. 
affectionate，and positive social 
interaction 
Social Provisions Support from family, friends, and Russell and Cutrona 
Scale coworkers related to attachment, 
social integration, guidance, 
reassurance of worth, and 
opportunity for nurturing 
* • «. 
• Behavioral section 
Behavioral section includes those behaviors patients attempt to change in order 
to reduce risk. The tools are presented in table 1.9. 
Table 1.9: Behavioral Tools. 
Tool name Tool measures Author(s) 
1 Diet-related tools 
Block Food Calories, fat, fiber, protein, Gladys Block 
Questionnaire carbohydrate, saturated fat, linoleic 
and oleic acids, and 10 vitamins 
and minerals 
Diet Habit Survey Cholesterol-saturated fat intake, Connor SL, 
complex carbohydrates, and salt Gustafson JR., et al 
Harvard-Willett Calories, fat, protein, carbohydrate, Willett W C . 
Food Frequency saturated fat, linoleic and oleic 
Questionnaire acids, cholesterol, vitamins, and 
minerals 




2 Health Education Tools 
Health Knowledge What pulmonary rehabilitation Hopp JW., Lee JW.,^ 
Test participants have learned Hills R. 
* • «. 
1.5.5 Result 
Comprehensive pulmonary rehabilitation has been shown to be a cost-effective 
means of producing significant benefits for patients with C O P D . Many studies over 
the past several decades provide a sound scientific basis for the general intervention 
and specific components of such programs. (Ries, 1990). The benefits from 
pulmonary rehabilitation can be described in terms of the gains made during the course 
of the program and also maintained in the ensuing months and years following the 
program. Pulmonary rehabilitation studies compare heterogeneous patients and 
heterogeneous programs. Yet most studies show the same or similar results. The 
results of pulmonary rehabilitation are described in the following section. 
1. Static Lung Function 
Pulmonary rehabilitation programs have not resulted in a significant 
improvement in testing pulmonary mechanics or gas exchange values in patients with 
C O A D almost unanimously (Ries AL, 1990; Celli BR, 1995). As we known, lung 
function testing, especially spirometry, describes the patient's level of physiologic 
deterioration, but it is a poor predictor of how well a patient is likely to benefit from a 
rehabilitation program. 
2. Cost-benefits 
Several studies have demonstrated the cost-benefits of pulmonary rehabilitation, 
* • «. 
which results in decrease in use of medical resources, include hospitalization days, 
emergency rooms, and physician office visits. Petty and associates reported a decrease 
in hospital days from 868 to 542(38%) for 85 patients 1 year after the conclusion of 
pulmonary rehabilitation. (Petty TL, 1969). Johnson and colleagues similarly reported 
a 55% decrease in days of hospitalization for 96 patients over a similar 
period.(Johnson HR，1980). 
Moreover, several reports indicate rehabilitation programs are also cost-
effective on a long-term basis. For example, a study has shown that a reduction in the 
hospital stays of 64 patients after rehabilitation was maintained over a 4-year period 
(73% reduction in the first year and 61% in the fourth for the 44 patients who 
survived)(Hudson LD, 1976). Although not all aspects of rehabilitation are likely to be 
cost-effective, cost should not be the predominant factor in determining the 
effectiveness of rehabilitation programs. 
3. Dyspnea 
After rehabilitation, patients have an improved quality of life with a reduction in 
reduction in respiratory symptoms, particularly of dyspnea. Nine studies published in 
recent years have measured dyspnea before and after a comprehensive pulmonary 
rehabilitation, include five outpatient pulmonary rehabilitation, two inpatient 
pulmonary rehabilitation, and two pulmonary rehabilitation in the home. All studies 
* • «. 
have shown an improvement in dyspnea following pulmonary rehabilitation. 
The three randomized studies and one nonrandomized study using more recent, 
valid, and reliable measurements found significant decreases in dyspnea during 
laboratory exercise testing for the group that had completed comprehensive 
pulmonary rehabilitation compared to a control group. For example, in the 
randomized studies, Goldstein and colleagues reported significantly greater 
improvement in C R Q (dyspnea, fatigue, emotion and mastery) and BDI/TDI for 
rehabilitation group compared to controls for 89 patients (Goldstein RS, 1994); Ries 
and colleagues reported Borg scale ratings of perceived breathlessness during 
endurance exercise test improved significantly in rehabilitation group up to 24 months 
vs no change in controls; S O B Q improved significantly in rehabilitation group up to 6 
months vs no change in controls for 119 patients (Ries AL, 1995). In turn, the relief of 
dyspnea supports the overall program as it reinforces patient motivation. 
4. Quality of Life 
Quality of life is one of the most compelling determinations attempted in 
evaluating pulmonary rehabilitation. It is also lush with conjecture and pitfalls. One 
investigator: McSweeny breaks quality of life into the following components: 1) 
emotional functional functioning; 2) social role functioning; 3) ability to perform ADL; 
4) ability to participate in enjoyable activities.(McSweeny, 1988). 
* • «. 
Among investigation of pulmonary rehabilitation outcomes in patients with 
C O P D in recently years, there are nine articles that used standardized Q O L outcome 
measure tools. Two of the three randomized controlled studies of pulmonary 
rehabilitation demonstrated improved QOL, Goldstein and coworkers utilized a 
disease-specific measure of QOL(CRQ) and demonstrated significant benefits in 
patients receiving rehabilitation compared to patients receiving only conventional 
medical treatment. Statistically significant benefits were achieved in emotional 
function and mastery, and there was an improvement that was not statistically 
significant in the fatigue scale of the C R Q (Goldstein RS，1994). Studies by Wijkstra 
and coworkers have demonstrated both short- and long term improvements in Q O L 
following pulmonary rehabilitation as measured by the CRQ.(Wijkstra PJ, 1994). But 
in a 6-year study by Ries and coworkers, no benefits were seen in Q O L by using Q W B . 
(Ries AL,1995) Two of the three randomized trials that employed only limited aspects 
of pulmonary rehabilitation have demonstrated improved QOL. A weight-lifting 
exercise program without comprehensive rehabilitation improved Q O L as measured 
by the CRQ.(Simpson K, 1992). Cognitive modification and a combination of 
cognitive and behavioral modification added to exercise training resulted in improved 
Q O L measured by the Q W B (Atkins CJ, 1984). However, Q O L measured by the 
Q W B did not change in patients receiving dyspnea management interventions (Sassi-
* • «. 
Dambron DE, 1995). All three nonrandomized trials of pulmonary rehabilitation used 
the C R Q and demonstrated improved Q O L up to 11 months following rehabilitation 
(Guyatt GH,1987; Vale F, 1993; Reardon J，1993). 
5. Exercise performance 
Exercise performance improvement is one of the most striking and consistent 
outcomes of pulmonary rehabilitation. Exercise protocols have varied widely from 
low-intensity, slowly paced walks, to high-intensity bicycle ergometry and treadmill 
protocols. Most studies performed over the last thirty years have used symptom-
limited protocols like walking tolerance. These studies almost unanimously 
demonstrated improvements in exercise endurance and maximal exercise tolerance; 
the few studies based on high-intensity training showed improvements in anaerobic 
thresholds.(Casaburi R, 1991). Punzal and coworkers reported a significantly greater 
increase in exercise endurance for the rehabilitation patients.(Punzal PA, 1991). In 
this study, exercise endurance was measured at the highest, symptom-limited exercise 
level and averaged 95% of baseline maximum treadmill workload. For patients in the 
rehabilitation group, exercise endurance increased from 12.5 min at baseline to 23.6 
min after the 2-month intervention. For education control patients, exercise endurance 
increased from 11.5 min to only 12.9 min after 2 months. (pO.OOl) (Fig. 1.5). They 
also indicated significant improvement in maximum exercise tolerance after 
* • «. 
rehabilitation. 
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Note: Results of endurance exercise test in a randomized clinical trial of 
comprehensive pulmonary rehabilitation versus an education control group in 119 
patients with C O P D tested at baseline and after intervention at 2,6,and 12 months of 
follow-up. 
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6. Survival 
By now, no studies have convincingly demonstrated that pulmonary 
rehabilitation programs lengthen survival. Nevertheless, there is important evidence 
that the comprehensive approach involved, which concentrates medical expertise 
longitudinally on patient care, may improve life expectancy by identifying problems 
and initiating treatment early.(Petty TL，1980). Examples include smoking cessation, 
better compliance with LTOT, improved nutrition, exercise and an active lifestyle, 
avoidance and early treatment of exacerbation. All of which are of obvious immediate 
prognostic significance. 
Survival likely varies in relation to the component of C O P D that predominates, 
emphysema, asthma, or bronchitis, in the patients studied. Patients with a large degree 
of reversibility will likely benefit from a therapeutic approach that targets 
inflammation (Hodgkin JE, 1990). 
7. Others 
According to the improvement of exercise tolerance, level of physical activity, 
and reduce dyspnea, patients after pulmonary rehabilitation have more independence 
and ability to perform activities, include self-care, mobility, eating, home management, 
and social and recreational activities (Ambrosino N, 1995). Together with 
improvement in psychological function with less anxiety and depression and 
* • «. 
increased feelings of hope, control, and self-esteem. 
Furthermore, patients with less severe disease may be able to return to work and 
increase their performance of vocation. The success of vocational rehabilitation will 
also depend on factors other than the degree of respiratory impairment, including the 
patient's age, motivation, level of education, capability for retraining, physical 
demands of a particular job, and support and understanding from an employer. 
(Ries, 1990) 
* • «. 
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2.1 What is knows — Hong Kong elderly population database 
2.1.1 Elderly population 
In Hong Kong, the population aged 65 and above has been classified as the 
elderly population. It has been divided into different age groups 一 the young-old, the 
old-old and the oldest-old, arbitrarily defined as the age groups 65-74, 75-84, and 85 
and above (Ho SC, 1992). 
2.1.2 Aging in Hong Kong 
The population of Hong Kong has always been thought to be young. In 1980, 
.1 
! 
40%were below the age of 20, and the median age of the population was 25. Today, as 
a result of decreasing birth rate and increasing life expectancy, Hong Kong's “ 
c 
1 
population has been aging steadily (Lam SK, 1997). Among 6.3 million mid-year •‘ 
t 
population of Hong Kong in 1996，about 10% were aged 65 and above. By the year ： 
2000, it is estimated that 10.6% of the population will be aged 65 and over, by 2006, : 
reaching 11%, and by 2010，11.3%.( Chan M , 1997) 
The population age pyramid 1966, 1996, and 2006 is shown in fig.2.1 (Hospital 
Authority, 1997). 
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Fig 2.1: Population Age Pyramid 1966, 1996，2006 
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Note: 1966 and 1996 figures refer to estimated mid-year population (Exclude 
Vietnamese Migrants) 
2006 figures refer to projected mid-year population (Exclude 
Vietnamese Migrants) 
(Source: Census & Statistics Department) 
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2.1.3 Health status of the elderly in Hong Kong 
As the elderly group has a heavy reliance on medical and social services, 
acquiring essential knowledge on the health status of the elderly in Hong Kong is 
important for the future planning of elderly services. 
Ideally there should be a central register of prevalence and incidence of chronic 
diseases and disability. In the absence of such a register, information is gathered from 
three studies about various community surveys of the elderly population. Include 1) 
Hong Kong Society for the Aged in 1994; 2) A Report of Health and Medical Service ' 
Needs of the Elderly in the Central and Western District 1996; 3) Social and Health 
> 
1 
Profile of the Hong Kong Old-old Population 1992. j 
1 t 
Chronic illnesses are common among the elderly. The eight commonest chronic 1 
»» 
t' 





l - J 
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Table 2.1: The eight commonest chronic diseases among the elderly in Hong Kong 
Study 1 Study 2 Study 3 
Total data 1408 ^ 2032 
number 
Subject group >60 years > 65 years > 70 years 
disease N u m b e r N o ( % ) Number No(%) Number No(%) 
R h e u m a t i s m m J U T ^ 34：2 729 ^ 
Hypertension 474 y22 89 3^1 643 31：6 
Peptic u l c e r m iXS 2l 7l 329 
Coronary ^ ^ m T O 
heart disease 
Diabetes FSS 40 13：5 TlO 丨 
mellitus 




Asthma ~ “ 16 5A 105 ^ 丨 
Stroke 55 ^ 19 M 162 O 丨 
Note: Study 1: Hong Kong Society for the Aged in 1994 (Leung MF, 1994) 
Study 2: A Report of Health and Medical Service Needs of the Elderly in the 
Central and Western District 1996 (中西區老人健康及醫療需要調查報告1996) 
(Chu L W , 1996) 
Study 3: Social and Health Profile of the Hong Kong Old-old Population 1992. 
(Ho SC，1992). 
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The percentage distribution of prevalence of known chronic disease is similar 
among above three studies. Chronic diseases are common in the elderly. About 81% of 
subjects had at least one chronic disease while 24.3 suffered from five or more chronic 
disease. (Chu L W , 1996). For those aged 70 years and over, the diseases constituting 
the greatest burden are arthritis, hypertension, cardiac disease, peptic ulcer, 
osteoporotic fractures, diabetes mellitus and chronic obstructive pulmonary disease 
(Woo J, 1997). 
I . ；) 
Although there is no central registry for elderly with chronic respiratory diseases, 
1 
a population survey of respiratory symptoms and diseases in Ho SC and coworker's 丨丨 
1-I 
1! 
study showed that in more than 2000 elderly Chinese in Hong Kong, about 55.5% of , 
i 
the subjects studied complained of one or more respiratory symptoms ( Lai C K W , \ 
？ 
1995). In the study of Chu L W and coworker showed that 21.3% subjects complained J 
！I 
of short of breath, and 2.4% complained of cough among 296 elderly which lived in i 
the central and western district, Hong Kong. 
2.2 Service provision for the elderly in Hong Kong 
2.2.1 Geriatric Medicine in Hong Kong 
Geriatric medicine has been defined as the branch of general medicine which 
deals with the clinical, rehabilitative, psychosocial and preventive aspects of illness in 
* • «. 
elderly people. (Coni N，1988). Over the past 50 years, geriatric services and 
departments were established nationwide in the United States, Canada, the 
Netherlands, the Irish Republic, Spain, N e w Zealand, Australia, and Hong Kong. 
(Steel K, 1993). 
Based on the British model, the first geriatric unit was established in 1975 in 
Hong Kong, which was ahead of the rest of Asia. With the development of geriatric 
services in the past 20 years, at present, there is at least one geriatric service per 
hospital cluster. The history of geriatric services in Hong Kong is shown in table 2.2. 丨 
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Table 2.2 History of geriatric services in Hong Kong (Chu L W , 1997) 
Year Hospital Unit 
1974 nited Christian Hospital Geriatric ward 
1975 Princess Margaret Hospital First formal Geriatric Department in 
Hong Kong 
1978 Caritas Medical Centre Geriatric Department 
1982 Kwong W a h Hospital Geriatric Department 
1985 Prince of Wales Hospital and Geriatric Team (flilly integrated 
Shatin Hospital (1991) model) 
1990 Ruttonjee Hospital Geriatric Department 
1990 Tuen M u n Hospital Geriatric Department 
1991 Haven of Hope Hospital Geriatric Assessment and 
Rehabilitation Unit 
1993 Queen Elizabeth Hospital Geriatric Team (fully integrated model) ‘ 
1994 Queen Mary Hospital and Geriatric Division (flilly integrated ‘ 
！'i 
Fung Yiu King Hospital odel) 
I 
1994 Yan Chai Hospital Medical Rehabilitation and Geriatric '! 
Unit ^ 
1995 Pamela Youde Nethersole Geriatric Division (fully integrated ) 
Eastern Hospital model) ^ 
i 
1995 ong Chuk Hang Complex for eriatric Department ； 
the Elderly ！ 
1995 St. John Hospital Geriatric Department 
1995 Wong Tai Sin Hospital Geriatric Division 
1996 Our Lady of Mary knoll Geriatric Department 
Hospital 
In general, the service structure of geriatric medicine is moving towards a fairly 
uniform format. At present, a typical cluster-based geriatric service includes in-patient 
and out-patient, a day hospital and a community outreach service. These service set-up 
* • «. 
greatly facilitate the practice of progressive patient care for elderly patients (Lawson 
JS, 1995). 
As elderly people have multiple needs, which include social, psychological, 
physical health and functional status aspects, a multi-dimensional (Rubenstein LA, 
1992) and multi-disciplinary team approach is the cornerstone of success in geriatric 
service program. The key dimensions to assess and manage in elderly include their 
physical health/disease status, functional status, psychological health status, and 
socioeconomic and environmental status; while the multi-disciplinary geriatric team ； 
f； 
include core members and supporting members, which is summarized in table 2.3 (Fox , 
f 
R A , 1993). ： 
i 
V I, 
Table 2.3 The Multi-disciplinary Geriatric Team 
7 
} 
Core members Support members { 
- I 
• Geriatrician • Dietitian 
• Nurse • Podiatrist 
• Social worker • Speech therapist 
• Occupational therapist • Prosthetic and orthotic specialist 
• Physiotherapist • Psychogeriatrician 
• Clinical psychologist 
• Volunteer 
• Pastoral care 
* • «. 
2.2.2 Residential homes for the elderly in Hong Kong 
A full range of resident facilities for the elderly is available, and consists of the 
old age hostels, homes for the aged, care and attention homes, nursing homes, and 
infirmaries. (Working group on the care for the elderly, 1994). The present services are 
provided by the Hospital Authority, the Department of Health, the Social Welfare 
Department and non-government organizations together. As at 1 April 1998, the 
capacity of Government and Subvened residential homes for the elderly in Hong Kong “ 
i 
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Table 2.4: Capacity of Government and Subvened residential homes for the elderly 
Region No. of Capacity 
Home Hostel Homes for C & A Nursing Total 
§ 
aged Home Home 
Hong K o n g 2 1 ^ U U 0 
9 138 276 743 0 USl 
Kowloon 
ISst 2l n e 1663 i m 0 3 1 ^ 
Kowloon 




" N ^ ^ n ? 1479 r^IS 0 3 4 2 6 ； 
Territories ‘ 
(West) , 
" T ^ 112 925 6843 W T l 200 15979 '' 
I 
； I 、 
•i 
t 
Besides residential services, the community support services is another main j. 
. . . i 
categories of designated social services for the elderly in Hong Kong. It includes , 
U s 
multi-services centres, social centres, day care centres and home help services, which 
aim to support elderly persons to live in the community as long as possible. 
2.2.3 Hospital Authority programs for the elderly 
According to Hospital Authority Annual Plan 1997/98, the H A plan to 
development of services for the elderly include: 
* • «. 
• Carry out an additional 600 cataract surgery operations for elderly patients with 
cataract 
• Improve podiatry service by introducing H C A s into Podiatry to reduce waiting 
time for first attendance to 8 weeks 
• Set up 3 frail elderly clinics to provide early multi-diciplinary assessment for high 
risk elderly in the community to reduce rate of institutional care by 10% 
• Set up 1 additional Community Geriatric Assessment Team (CGAT) to serve an “ 
additional 1625 patients per annum | 
H A plan to improve service for chronic lung diseases, too. It will focus on j 
improving patient education not only in smoking cessation but also in the treatment -
i 
• 
and monitoring of their own diseases, and reduce non-compliance with treatment 乂 
；<： 
programs. Two pulmonary rehabilitation teams will also be established to serve 4000 ^ 
• . 1 
patients. Such teams will have the important mission of patient education, functional , 
s 
rehabilitation, and home oxygen therapy, to reduce disability, prevention of 
exacerbation and re-admissions. (Rehabilitation Division Health and Welfare Branch 
Government Secretariat, 1996) 
* • «. 
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W e propose to develop a Domiciliary Pulmonary Rehabilitation Program 
(DPRP) targeted at institutionalized elderly with C O A D living in residential homes to 
improve their exercise tolerance and Quality of Life (QOL). 
Not only short-term efficacy but also the long-term benefits will be tested in 
this research program. 
Pulmonary Rehabilitation Program (PRP) is an individually tailored, multi- “ 
disciplinary program aimed at preventing and reversing the disability associated with | 
s 
chronic lung disease, return patients to their highest possible functional capacity. 
•F 
In 1995, a small pilot project taken in Shatin Hospital, Hong Kong involving 15 
n . 
• y 
patients using a six weeks inpatient program demonstrated improvement in a reduction 《 
；、 
in subjective perception of shortness of breath and improvement in six minute walking 广 
) 
s, 
test (6MWT). ,, 
1 
A n alternative cost-effective domicilliary program of proven value has to be 
sought to improve the physical status of elderly with C O A D in Hong Kong. 
* • «. 
3.2 Subjects and Methodology: 
3.2.1 Subjects 
3.2.1.1 Patient selection 
All residents (>60 years old) of residential homes under care of the Community 
Geriatric Assessment Team (CGAT) (NT East region) who have a history of chronic 
respiratory problems will be invited to participate this program. There are 25 
residential homes which are located in Shatin and Taipo region under care of C G A T of 
I 
Shatin hospital, including 12 C & A homes and 13 Hostel for the Elderly, provide about \ 
�) 
3400 beds to the elderly. They will be included in the study if they are willing to 丨 
participate in exercise training program to improve their physical status and do not 
'I 
have any of the following contraindication: ‘ 
• Cognitive impairment (MMSE<13) to the degree that they may not be able to . 
s 




but <17 will try to participate with careful supervision; 
• Active or symptomatic cardiovascular disease(e.g., active congestive heart 
failure, ischemic cardiac disease) and symptomatic peripheral vascular disease 
that limit their exercise; 
• Current smoker and not willing to quit. 
• Recent hospital admission for exacerbation of chest condition(e.g., acute cor 
* • «. 
pulmonale, severe pulmonary hypertension) within the past one month of 
discharge from hospital; 
• Other medical conditions to the degree that limit their mobility to perform 
exercise training.(e.g., poor eyesight, severe deafness, osteoarthritis, disabling 
hemiparesis); 
• The Nursing Home where the elderly resides cannot afford to have at least one 
staff to supervise the patient to perform the exercise program; -
• Patients who do not give consent to the study. i 
t 
An estimation from Community Geriatric Assessment Service (CGAS) 丨( 
showed that about 10% of the institutional elderly in Hong Kong suffered from 
chronic respiratory problems. W e estimate that about 340 elderly should participate in ^ 
� 
this program. However in practice, only 22 residential homes (11 C & A homes, 11 
Jj 
5丨 
Hostel for the elderly) are willing to participate in the program, total provide 162 … 
I 
M I 
elderly to screen. In addition, 3 C & A home under care of C G A T (South Hong Kong 
Island), total 23 elderly are invited to participate. 
Table 3.1 shown the number of subjects through various modes of Nursing 
Home: 
* • «. 
Table3.1: Distribution of subjects in Nursing Home 
Modes of Number of Nursing Number of subject Valid percent(%) 
Residential Home Home 
C&A Home TI 110 59^ 5 
(NT East) 
H ^ n 52 2 0 
(NT East) 
C & A Home 3 23 124 
(HK island) 
T ^ 25 r ^ TOO 
i 
；1. 
3.2.1.2 Screening test 、；、 
丨. 
All subjects in the list which were provided by staff of nursing home 一 whether I 
study cases or not - were screened to assess for accurate diagnosis of the underlying I 
respiratory problems. The screening procedure included medical history, symptom 
assessment and diagnostic tests. Spirometry pre- and post-bronchodilator test were ^ 
performed to assess the extent of reversibility of any airway obstruction and the 
obstruction severity. Medication (including oxygen therapy based on the British 
Thoracic Society recommendation) were revised if necessary. Those subjects in w h o m 
the diagnosis of C O A D was confirmed, fulfilled the inclusion criteria and did not have 
any of the exclusion criteria will be invited to participate in the study. 
* • «. 
Table 3.2: Reasons for exclusion and the number of study cases: 
Reason for Number of subject Valid 
exclusion excluded percentage(%) 
fevl/fvc>0.70 or age 45 409 
<60 
Cognitive 21 T^l 
impairment 
Physical condition as 15 13.6 
barrier 
Not C O A D 9 O 
Unwilling to 7 6.4 . 
participate 1 
Current smoker and 7 6.4 考 
refuse to quit 
Other medical 5 4.5 i, 
• • I 
condition as barrier I 
Died before"""‘ 1 ^ 
intervention { 
t ^ n o 100 i 
il 
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3.2.2 Study design 
3.2.2.1 Estimated sample size 
In previous study, we found that six minute walking test (6 M W T ) is the most 
sensitive index in outcome measure of pulmonary rehabilitation program. Based on 
the assumption that there will be a 10% improvement in six minute walking test, we 
aim to achieve a power of 80% using p<0.05 as statistical significant level, calculation 
of sample size for a study using the student t-test is listed at table 3.3 below: -
；' 
ii 、 
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Table 3.3 calculation of sample size. 
Part 1: data on which the calculation will be based: 
Study characteristic Assumptions made by investigator 
Type of study Prospective controlled clinical trial of 
exercise training of PRP 
Data sets “ Observations in one experimental group and 
one control group of the same size 
variable 6 minute walking test 
Standard deviation (S) T07 “ 
i 
Variance (S, 11449 ~ | 
i(叫 
Data for alpha (Zj P=0.05; therefore, 95% confidence desired « 
(two-tailed test); Z^ =1.96 
I 
Difference to be detected (d) 62 meters (15% of mean distance) difference .. 
. J 
between mean 6 minute walking distance of 、 
the exercise group and control group(mean 、 
distance:413) ；l 
I — — — " h 
Part 2. Calculation of sample size (N): “ 
J ‘ 
N = (zj2x2x(s)"(d” “ 
=(1.96)2x2x (107)2 /(62)2 
= (3.84)(2)(11449)/(3844) 
=23 
二 subject per group x 2 groups 二 46 subject total 
(Butland RJA, 1982) * • «. 
3.2.2.2 Prospective controlled clinical trial 
All residents within the existing 30 nursing homes under C G A T (NTE) who 
fulfilled the inclusion criteria and did not have any of the exclusion criteria were 
invited to participate in the study. Randomization was based on the Residential Homes 
where the potential subjects reside. However in practice, it is difficult to randomized 
equal number of Residential Homes to be in the active treatment group and control 
group. So, the residential homes cannot afford staff to supervise the patients to perform -
ii 
the exercise program were put into the control group. ；j 
ja 
The control group had their medications optimized in the same manner as the 
I 
intervention group. However, there was no physical training program towards '' 
1， 
improving exercise tolerance. Patients were encouraged to perform as much exercise ( 
i 
\ 
as far as their tolerance could reach. 
；1 
3.2.3 Intervention ^ 
• t -
3.2.3.1 Optimization of medical treatment 
Once the diagnosis was confirmed, mainly through medical history, symptom 
assessment and pre- and post-bronchodilator test, medication was reviewed by the 
specialist in Shatin Hospital. An education talk was given to the staff in each nursing 
home regarding knowledge of the disease, medication used and inhaler technique. 
3.2.3.2 identifying the impact of the disease on the patient's daily living 
* • «. 
Once the diagnosis was confirmed, the impact of the disease on the patient's 
daily living, whether treatment group or control group, was identified. It included 
activities of daily living assessment and exercise assessment. 
3.2.3.3 Physical training program 
Once the study cases were selected, the medical condition stabilized and team 
assessment finished, physical training program was stated in the nursing home. The 
principle of the training program is one of symptom limited, endurance exercise 
1 . 1 
！丨 
training. The training component include: rS 
1. breath retaining: pursed-lips breathing training; 广 
丨 
diaphragmatic breathing training 
丨r 
2. exercise training: Graded free weights raising by arm raising; 〈 
. 
Stepping exercise ,, 
,1 
3. Coordinated breathing in activities of daily living task and symptom ‘ 
I , 
management 
The total duration of physical training is 12 weeks. During the first two weeks, 
each components of the training was taught to patient and a designated Health Care 
Worker (RN/EN staff or Patient Care Worker) in Residential Homes once per week. 
Patients were advised to do the exercise under supervision at two sessions daily, and at 
least five days per week after inhaled bronchodilators and at least 2 hours after food. 
* • «. 
They were grouped together at a designated room to do the exercise for ease of 
supervision by one Health Care Worker and also to enhance communication between 
each patient. Tolerance of patient to each activity (as limited by patient's self 
perceived symptom) was assessed as baseline for the exercise training and a simple 
diary card kept as record to check compliance to program. From week three to week 
twelve, each patient was seen once per 2 weeks to review the progress, with an aim of 
upgrading the activity level. Pursed-lip breathing and diaphragmatic breathing were ‘ 
ii 
practiced regularly and monitored once per 2 weeks. Unsupported, free weights arm j 
. .. lis 
raising above shoulder was performed with a recommended stepping up at additional 
3-5 times/session every two weeks. Likewise, stepping exercise was increased by 5-10 
卜 
steps/session every two weeks if the patient could tolerate it. Exercise increments were ；J 
I 
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Three interview were carried out at baseline (week 0)，at completion of training 
program (week 12) and 9 months (week 48).The same measurements of various 
parameters were performed in both the exercise and control group. 
Various parameters in each interview are listed below: 
* • «. 
Week 0: 
Demographic factor: age, sex, 
Coexisting medical conditions: the present illness review or those affecting functional 
activity; 
Chest conditions: smoking history, tuberculosis history, symptomatology, 
current respiratory condition, drugs history 
Baseline parameters: ~ 
J 
A. Knowledge (what, when ,how) on the medication used ：{ 
？ 
B. Technique on the inhalation drugs “ 
C. Pre- and Post-bronchodilator spirometry measurement ：• 
r 
D. Oxygen saturation as measured by pulse oximeter '! 
{ 
E. Quality of Life questionnaire: ， 
, 1 
1. A D L performance score; ‘ 
"I 
2. Geriatric Depression Scale (GDS); 
3. Philadelphia Geriatric Center Morale Scale(PGC); 
4. St George Chronic Respiratory Questionnaire (SGRQ) 
E. Exercise tolerance: 
1. 6 minutes walking test (6 M W T ) 
80 
2. Stairs climbing test 
3. Bicycle ergometer test 
At week 12 and week 48 
A. Knowledge (what, when ,how) on the medication used 
B. Technique on the inhalation drugs 
C. Pre- and Post-bronchodilator spirometry measurement ~ 
I 
D. Oxygen saturation as measured by pulse oximeter / 
.1 
E. Quality of Life questionnaire: '' 
1. A D L performance score; '' 
I-
2. Geriatric Depression Scale (GDS); 
/ 
3. Philadelphia Geriatric Center Morale Scale(PGC); 、 
,1 
4. St George Chronic Respiratory Questionnaire (SGRQ) 
> I 
F. Exercise tolerance: 
1 • 6 minutes walking test (6 M W T ) 
2. Stairs climbing test 
3. Bicycle ergometer test 
* • «. 
3.2.5 Content of questionnaire and exercise test 
a. A D L performance Score 
A D L performance Score is a 20 item instrument, which measure the subjects' 
function at home through described degree of short of breath when performing each 
activity. 
The instrument is divided into five categories of function: class five, four, and three 
represent basic activity; class two and one represent higher levels of activity. 脑 
I 
Class 5: sit down at rest or watch TV, charting, eating at the table, grooming; j 
• V 
:：! 
Class 4: get up, dressing, managing at the toilet; ‘ 
3 
Class 3: bathing, light meal preparation, light cleaning; 
I ‘ 






Class 1: grocery shopping, hard housework, other community activities. 
It is adopted by Occupational Therapy Department, Shatin Hospital, following 
the "Occupational Therapy Functional Activity Profile". Since it is a recently 
developed instrument, there is no data on reliability. 
Therefore we assessed the internal consistency and stability (interobserver 
variability and intraobserver variability) of the scale for patients in the Respiratory 
Ward of Shatin Hospital, by calculating the Cronbach's alpha and Spearman Rank 
* • «. 
Correlation. According to the standards of acceptable reliability, if internal 
consistency is not less than 0.8, and stability is not less than 0.5, it should be 
acceptable(David LS，1995). Ninety patients with C O A D were recruited, and no 
patient was in an acute exacerbation phase at the time of investigation. The 
interobserver variability was assessed between an occupational therapist and the 
author independently, in the same patient within 3 days; the intraoberserver variability 
was assessed in the same patient within 1 day by the author. Table 3.4 showed results — 
- J 







* • «. 
Table 3.4 Results from the reliability analysis of A D L Performance Score 
I ADL performance S c o r e ^ 
Class 5丨Class 4IClass 3[Class 2IClass 1 iTotal 
ItiSi 4 4 4 4 4 20 
number 
Theoretical 0-20 ^ 0-100 
range 
O b s e r v e d W l O TTSO 26-89 
range 
Inter-item 0.53 ^ ^ ^ ^ ^ 




Cronbach's 0.78 076 0?76 顽 ^ ^ ？ 
alpha 3 
coefficient 




r variability ‘ 
Sig.(2- T555 Tooo ^ 'MO o.ooo ^ 
tailed) 





s i ^ 'Mo 'Mo Tooo T o ^ o.ooo 
tailed) 
Our results demonstrated a satisfactory internal consistency reliability and stability of 
* • «. 
the A D L Performance Score. 
1. Internal consistency: inter-20 item correlations range -0.12 to 0.80, Cronbach's 
alpha of total score is 0.89. 
2. Stability: Spearman correlation of interobserver variability is 0.890, correlation 
is significant at the 0.01 level (2-tailed); Spearman correlation of intraobserver 
variability is 0.990, correlation is significant at the 0.01 level. 
W e concluded that A D L Performance Score is reliable instrument. 
J 
b. Geriatric Depression Scale (GDS) ‘ 
\ 
The geriatric depression scale (GDS), is a simple 15 item screening instrument jj 
and in the recognition of depression in the elderly.(Yesavage JA，1983). 
It is recommended by the Royal College of General Practitioners highly ； 
acceptable in primary care practice as well as having excellent specificity and ) 
I 
sensitivity in detecting depressive illness. (D'Ath P, 1994; Williams EI, 1993) , 
1 
The G D S was translated into Chinese and validated in the local Chinese , 
population. It was found to be reliable and valid, with an optimum cut-off point of〉二8, 
with a sensitivity of 96.3% and specificity of 87.5% for detection of depression (Chiu 
HF,1994). 
W o o (Woo J, 1994) also reported that in a survey of elderly Chinese aged 70 
years and over living in Hong Kong selected by stratified random sampling, the 
prevalence of depression which determined using the G D S was 29.2%, 41.1%, and 
35.0% for men, women, and all subjects respectively. It is easy to use, taking only a 
* • «. 
few minutes to complete, and is therefore easily incorporated into large-scale surveys 
of elderly populations. 
c. The Philadelphia Geriatric Center Morale Scale 
The Philadelphia Geriatric Center Morale Scale (PGC), is a 17 item instrument 
measuring of life satisfaction and self-esteem, which was first reported by Lawton 
(Lawton,1972, 1975). 
Consideration of factors defined by the analyses suggested three consistently 
reproduced factors: Agitation, Attitude toward own aging, and Lonely dissatisfaction. -
• 11 
The P G C is used as the most popular scale among gerontologists, on the grounds of its ； 
�� 
superior results for reliability and validity. (Ann, 1994) i 
\ 
d. The St. George's Respiratory Questionnaire (SGRQ) 
J 
The St. George's Respiratory Questionnaire (SGRQ), developed by Jones et j 
al. (Jones, 1992), is a 50-item disease-specific instruments in chronic obstructive -
t 
pulmonary disease used to measure" health-related quality of life", that is the . 
impact of chest disease on daily life and well-being. 
The instrument is divided into three components: symptoms, activity, and 
impact on daily life. 
1) Symptoms: frequency of cough, sputum production, wheeze, breathlessness, and 
duration and frequency of attacks of breathlessness or wheeze. 
2) Activity: physical activities that either cause or are limited by breathlessness. 
* • «. 
3) Impact: covers such factors as employment, being in control of health, panic, 
stigmatization, the need for medication and side-effects, health expectations, 
disturbances in daily life. 
This division was supported by principal components analysis. (Jones, 1992). 
Each of the three components is score separately (0-100 percent), with a zero score 
indicating no impairment to life quality. A total core can be calculated for all item 
responses. The S G R Q scores are calculated using weights attached to each 
il 
questionnaire item. These provide an estimate of the degree of distress associated with { 
1 
the symptom/state. ； 
The S G R Q is designed as a supervised self-administered questionnaire. That 
*» 
means the patients should complete the S G R Q by themselves but someone must be [ 
I 
available to give advice if it needed. In this research program, the S G R Q was carried 
1 
out as a supervised questionnaire since most subjects have difficulties in 
<I 
understanding the questionnaire due to poor education. 
Jones, et, al (1992) reported S G R Q scores correlated with spirometry, 6-minute 
walking test, M R C respiratory symptoms questionnaire, the Hospital Anxiety and 
Depression Scale (Zigmond and Snaith 1983)，and the Sickness Impact Profile 
(SIP:Bergner et al. 1981).A total of 141 patients were studied, mean age 63 years 
(range 31-75) and prebronchodilator FEV,=47% (range 11-114%). S G R Q scores 
* • «. 
correlated with appropriate comparison measures. For example, symptom score versus 
frequency of wheeze, r2=0.32, p<0.0001; activity versus 6 - M W T , r2=0.5,p<0.001; 
impact versus anxiety, r2=0.38,p<0.0001. It was sensitive to changes in the reference 
measures over a period of 12 months. 
Jones, et al. (1992) also reported good reliability in relation to 2-week retest 
repeatability among 40 stable asthmatic patients and 20 patients with stable COPD, the 
coefficient of variation being 19%.the intra-class correlation for the total score was … 
I 
0.92. the repeatability of the component sections was similar for the patients combined f 
\ 
1 
(r=0.91 for symptoms, 0.87 for activity, and 0.88 for impact). : 
i 
Thus, the S G R Q is a valid measure of impaired health in disease of C O A D that is | 
I 
i 
repeatable and sensitive. ‘ 
1 
I 
e. Six Minute Walking Test, and Stair Climbing Test ‘ 
1 
The 6-minute walking test (6MWT) is a useful and reproducible measure of : 
exercise tolerance. (McGavin CR, 1976). It provides a simple, practical guide to 
everyday disability and does not require expensive apparatus. It can be performed by 
many elderly, frail, and severely limited patients who cannot be tested with standard 
maximal cycle ergometer or treadmill exercise tests.(Butland RJA, 1982) 
With the 6-minute walking test, subjects are instructed to walk from one end to 
the other of a 27 meters' hallway, while attempting to cover as much ground as 
* • «. 
possible in the allotted 6 minutes. Subjects are encouraged with the standardized 
statements "You're doing well" or "Keep up the good work". Subjects are allowed to 
stop and rest during the test, but are instructed to resume walking as soon as they felt 
able to do so. Dyspnea, as measured with the modified Dyspnea Index, oxygen 
saturation (Sao】)，and pulse rate are assessed at the start and end of the walk whether 
they had experienced any of the following symptoms : dyspnea, chest pain, 
lightheadedness, or leg pain. -
il 
Another test is stair climbing test. The method is similar to the 6 minute walking [ 
1 
•V 
test. The subjects are asked to climbing the 32 steps' stair, while attempting to climb as . 
J 
much steps as possible without time limits. They can allowed to stop at any steps due 
to short of breath. Dyspnea, oxygen saturation, and pulse rate are assessed at the start | 
I 
and end of the test. 
1 
Using these tests is common practice, although there is little information on 
J 
their reliability and validity apart from the associations with the Oxygen Cost 
Diagram ( McGavin ,1978), and the moderate correlations with lung function 
reported earlier (Eakin, 1993) 
f. Bicycle ergometry 
Bicycle ergometer exercise is one of common cardiopulmonary exercise testing 
* • «. 
which has been widely used in Europe and South America. As we known, 
cardiocirculatory limitation, ventilatory limitation, and diffusion limitation are the 
mainly factors due to exercise limitations in C O A D patients. The bicycle ergometer 
exercise is essential in the assessment of limitations for exercise performance, and 
consequently for the ensuing therapy. (Victor F, Gilberto D, 1989). 
The relation between work rate in watts and the multiple of one metabolic 
equivalent (mets) is: 
Mets = workrate(watt) / B.W.(kg) x 22/7 + 1 
To find the corresponding oxygen consumption (VO2), multiply mets by 
3.5ml/min/kg 
The protocol used was according to the suggestion by Jones and Campbell 
(Joseph S, 1986): 
The subject begins at the lowest work load setting - 25 watts, after 1 minute, 
load is automatically increased by 10 watts, and maintained for 1 minute. The cycle is 
then repeated until the subject can no longer maintain the correct pedal speed (30-50 
mph) due to short of breath or lower limb fatigue. Heart rate, SaO〗,blood pressure 
should be monitored during the course of testing. If any cardiovascular event 
(arrhythmia, SBP>250mmHg, DBP〉110mmhg, Heart rate>120) occurred, the 
exercise test was stopped. The pulse, SaO〗, and blood pressure pre- and post- the 
exercise , and duration of the test were recorded. 
3.2.6 Statistical analysis 
Paired t-test will be used to compare pre- and post- intervention mean 
differences in 6 M W T , stairs climbing, bicycle ergometer exercise testing, GDS, 
P G M S , S G R Q , and other physical parameters for individual patient. Values of p<0.05 
* • «. 
were considered to indicate significant differences. 
Student t-test will be used to evaluate the significance of differences between 
exercise group and control group the exercise tolerance (6MWT, stairs climbing, 
bicycle ergometer exercise testing), quality of life (GDS, P G M S , SGRQ,) 
Repeated Measurement of A N O V A ( M A N O V A ) will be used to compare the 
trend with time between the exercise group and the control group in the parameters of 
exercise tolerance (6MWT, stairs climbing, bicycle ergometer exercise testing), 
quality of life (GDS, P G M S , S G R Q ) 
3.2.7. Hypothesis 
In the next chapter, we will answer the hypothesis of this thesis that "Does 
Domiciliary Pulmonary Rehabilitation Program effectiveness in terms of exercise 
tolerance and quality of life?" 
The following questions will be addressed : 
Ql. Are there any differences in baseline (weekO) characteristics between exercise and 
control group? 
Q2: Are there any differences in short term outcome in terms of exercise tolerance and 
quality of life between exercise and control group at 12 weeks? 
Q3. Are there any differences in long term outcome in terms of exercise tolerance and 
quality of life between exercise and control group at 48 weeks? 
* • «. 
Q4. What account for the differences of Q2? (if any) 
Q5. What account for the differences of Q3? (if any) 
Q6. Are there any difference in long term outcome in terms of exercise tolerance and 
quality of life in exercise group between baseline and 48 weeks? 
Exercise group Control group 
Baseline(weekO) \ Baseline (weekO) 
^ Qi • 
“ t 
，rQ4 | Q 4 
Exercise group Q2 Control group 




Exercise Control group 
group ^ — • Fu-2(week 48) 
Fu-2(week 
48) 
* • «. 
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* • «. 
Seventy-five subjects were recruited to the study. There are forty-three cases in the 
exercise group, and thirty-two cases in the control group. During the rehabilitation 
period (12 weeks), eight subjects in the exercise group withdrew (died 2; still smoking 
2; cancer disease 2; readmission 1; move out 1); three subjects in the control group 
withdrew (move out 2; readmission 1); During the second follow up(48 weeks), three 
subjects in the exercise group withdrew (readmission 2; died 1); six subjects in the 
control group withdrew (died 3; unwilling to follow up 2; readmission 1). The number 
of each group and the causes of drop out was listed in table 4.1 below: 
Table 4.1 The number of drop out from PRP in the exercise group and the control 
group 
Number of iNumber of iNumber of total 
control group exercise group 
Baseline (0 week) ^ 43 75 
First Fu (12 weeks) 29 ” 64 
Second Fu (48 weeks) 丨23 “ [32 林' [55 
Causes of drop out: 
” • move out: 2; readmission: 1 
*2 died: 3; unwilling to follow up: 2; readmission: 1 
射 died:2; cancer disease:2; still smoking:2; move out: 1; readmission: 1 
died: 1 ； readmission: 1 
The mean age of those 20 drop out subjects was 81.5, which is not significantly 
different from other subjects. The compliance of the exercise training in the exercise 
group was above 80% as predicted. 
* • «. 
4.1 Results at baseline 
Results of baseline characteristics of exercise group and control group are shown 
in table4.1-a as below: 
Table 4.1-a: baseline characteristics of patients who participated in the study program 
(exercise group and control group): 
variable Total Group Difference 
(exercise + (p-value) 
control 




Sex (M/F) [37738 p272i [TsTl? 
Age (yrs) f 80.83±6.14 81.33+5.84 80.16+6.55 0418 
Cognitive Function 
MMSE(0-30)卞21.36+4.79 21.88±4.76 20.66±4.80 [0：275 
Others 
Weight (kg)卞 49.08士11.02 50.13±12.02 47.67±9.50 0.342 
Diag- C O A D ^ 33 28 ™ 
nosis 
Chronic 9 7 2 ™ 
asthma 
Bronchie 5 ~3 2 ^ 
ctasis 
t: student t-test 
Overall, there was no difference between exercise group and control group in 
baseline characteristics. Patients who participated in the study program belonged to 
the old-old population. 
* • «. 
The results of physical assessment,exercise tolerance test, and Quality of Life 
assessment between exercise group and control group at baseline using student t-test 
and Mann-Whitney test are shown in table 4.1-b ,and table 4.1-c as below: 
Table 4.1-b: Mean (SD) values in Physical assessment, Exercise tolerance exercise 
and control groups at baseline:卞 
Variable Group 
Control group I Exercise group p-value 
(n=32) (n=43) 
Physical assessment 
PEFR(L/min) 1160 (70) 1151 (85) [0632 
Sp02 rest(%) 94.0 (4.2) 94.4 (2.9) O l ^ 
FEVl(L) 0.65 (0.29) 0.57 (0.22) 0215 
FEVl%predict 46.34(13.73) 42.79 (20.07) 0407 
FER(FEV1/FVC) 0.56 (0.10) 0.53 (0.12) 0T27 
FVC(L) 1.12 (0.51) 1.09 (0.38) 0335 
Exercise tolerance 
6mwt(m) 1232.4(116.5) 1249.5 (98.7) l0305 
Stairs walking (steps) 54 (39) 60 (41) O S ^ 
BicycleiMets 6.89 (3.02) 3.87 (0.76) 0.000* 
ergometry 62 (38) 44 (11) OjO^ 
Duration(min)3.9 (3.8) 2.3 (1.2) M 6 9 
卞：student t-test * p<0.05 
* • «. 
Table 4.1-c: Median (inter-quartile range) values in Quality of Life (QOL) assessment 
between exercise and control groups % 
Control Exercise p-value 
A D L (0-100) 65 (58,75) 62 (58,73) 0463 
GDS(0-15)© 3.0 (2.0,6.0) 5.0 (2.8，7.0) 
PGMS(0-17) 13.0 (9.5, 15.0) 12.0 (8.8, 12.0) 0371 
S G R Q I Symptom46.7(36.4,61.0)54.7 (42.1,54.7) O W f 
(0-100)© 
Impact 19.8 (9.3,42.6) 33.3 (14.7,52.6) 0A77 
Activity 38.9 (16.1,70.6)49.3 (32.7, 68.2) 0063 
Total score26.7(19.1,41.8)^42.5 (29.0，49.1) O M T * 
t : Mann-Whitney test * p<0.05 ©: the higher score, the poorer condition 
The patients had moderate to severe expiratory flow obstruction, but the exercise 
group had a worse condition than control group. For the exercise tolerance test, it can 
be seen in table 4.1-b that there is a significant difference in Mets during the bicycle 
ergometry test. It can be also seen in table 4.1-c that there is a significant difference in 
S G R Q score, representing more symptoms in the exercise group. It is possible that 
subjects with different levels of disability were not distributed evenly among the 
nursing homes. 
* • «. 
4.2 Trend with time (0 week, 12 weeks, 48 weeks) between the exercise group 
and control group in physical assessment, exercise tolerance test, and 
Quality of Life: 
The Repeated Measurement of A N O V A ( M A N O V A ) was used to compare the 
two groups' trend with time. The p value for the linear and quadratic model of the 
following variables were less than 0.05, showing significant difference with time: 
PEFR (linear p<0.05), FEVI (quadratic p<0.05), A D L , GDS，SGRQ (symptom, impact, 
activity, total score), 6 M W T , stairs climbing test, bicycle ergometry (duration, watts, 
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11) Bicycle Ergometiy (Mets) 
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There were large changes in terms of Quality of Life，Exercise tolerance, and 
physical assessment between the exercise group and the control group with time. 
There were significant difference between the two groups in PEFR, FEVl, A D L 
Performance Score, GDS, S G R Q (symptom, activity, impact, and total score), 6 M W T , 
Stairs walking, and bicycle ergometer (watt, duration).The trend with time in the 
exercise group was towards improvement followed by decline on stopping the 
program, while the control group had a pattern of stepwise deterioration. 
4.3 Results at first follow up (12 weeks) 
Results between the exercise and control groups after the 12-weeks rehabilitation 
program using the student t-test and Marm-Whitney test are shown in table 4.3-a and 
table 4.3-b as below: 
* • «. 
Table 4.3-a: Changes in Physical assessment and Exercise tolerance exercise and 
control groups at the first follow up (12 weeks) •• 
Control Exercise p-value Mean difference 
(n=29) (n=35) (95% CI) 
Physical assessment 
PEFR(L/min) 1152 (70) 1177 ( 9 3 ) 1 ^ 2 4 1 2 5： 2 8 
(-16.91,67.46) 
Sp02 rest(%) 94.7 (3.0) 95.1 (2.7) 0 . 5 6 1 ^ 
(-1.03, 1.88) 
FEVl(L) 0.63 (0.24)0.61 (0.22) 0.733 
(-0.14,0.01) 
FVC(L) 1.19(0.46)~1.16 (0.35) 0.805^ 
(-0.24, 0.19) 
Exercise tolerance 
6mwt(m) [2342 [28577 [0057[5^46 
(109.8) (109.1) (-1.66, 110.58) 
Stairs walking (steps) 47 (37) 87 (62) 0.002* 40 
(14，67) 
BicycleiMets 4.18 (0.87)4.36 (0.95) 0 . 4 8 4 ^ O T l ^ 
ergometry (-0.35,0.72) 
48 (14) 51 (13) 0432 
(-4.85, 11.29) 
Duration(min)2.5 (1.5) 2.8(1.4)0~473 
(-0.52, 1.12) 
卞 student t-test * p<0.05 
* • «. 
Table 4.3-b: Median (inter-quartile range) values in Quality of Life (QoL) assessment 
between exercise and control groups at first follow up (12 weeks) $ 
Control (29) Exercise (35) p-value * 
A D L (0-100) © 68 (53,78) 72 (63，80) 0l29 
GDS(0-15) 4.5 (3.0,6.0) 3.0 (2.0,5.0) 0064 
PGMS(0-17) 13.0(10.5, 14.8)13.0(11.0, 15.0) 0.533 
S G R Q © I Symptom 56.5 (35.9, 66.5)38.5 (24.0, 52.1) 0.053 
(0-100) 
Impact 19.5(10.0,32.0)11.1 (5.7, 17.5) 0.020* 
Activity 55.9 (30.5, 76.0)28.5 (15.5,44.5) 0.014* 
Total score 32.2 (22.8, 47.4)^19.9(15.1,33.2) 0.010* 
t Mann-Whitney test * p<0.05 ©： the higher score, the poorer condition 
There was no change in pulmonary function after 12-weeks of pulmonary 
rehabilitation. However there was significant improvement in stairs walking, and 
S G R Q (impact, activity, and total score) in the exercise group, inspite of a poorer 
performance at baseline. 
4.4 Results at second follow up (48 weeks) 
The results of physical assessment, exercise tolerance test, and quality of life 
assessment between the exercise and control groups at 48 weeks follow up using the 
student t-test and Mann-Whitney test are shown in table 4.4-a and 4.4-b: 
* • «. 
Table 4.4-a: Changes in Physical assessment and Exercise tolerance exercise and 
control groups at the second follow up (48 weeks)卞 
Variable Control Exercise p-value Mean difference 
(n=23) (n=32) (95% CI) 
Physical assessment 
PEFR(L/min) 1155 (77) 1182 (199) [0472[27Ji 
(-59.92, 115.34) 
Sp02 rest(%) 94.5 (3.3) 95.1 (3.1) 0 5 3 9 ^ 
(-1.18,2.25) 
FEVl(L) 0.65 (0.31)^ 0.57 ( 0 . 2 2 ) 0 3 2 2 ^ ^ 0 0 7 5 
(-0.22, 0.07) 
FVC(L) 1.21 (0.51)1.12(0.41)""0375^^0092 
(-0.34，0.15) 
Exercise tolerance 
6mwt(m) ]2A5J [244：7 ^ 3 7 8 [ 2 ^ 
(113.8) (123.5) (-37.09,94.92) 
Stairs walking (steps) 46 (25) 54 (38) 0 3 9 8 8 
(-12, 27) 
Bicycle[mSS 3.95 (0.86)4.29(1.24)~~0316"""0334 
ergometry (-0.41, 1.08) 
W ^ 44(11) 46(11) 0441 ^ i M 
(-4.62, 10.34) 
Duration(m 2.2(1.2) 2.4(1.1) 0 ^ 4 1 " " 0 2 ^ 
in) (-0.53, 1.01) 
卞 student t-test 
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Table 4.4-b: Median (inter-quartile range) values in Quality of Life (QoL) assessment 
between exercise and control groups at the second follow up (48 weeks) { 
I Control (23) lExercise (32) |p-value 
A D L (0-100) 66 (55,78) 67 (56,76) 0.975 
G D S ( ( M 5 ) © 4.0 (2.3,5.8) 4.0 (2.0,7.0)~0875 
PGMS(0-17) 13.0(11.0, 14.0)~13.0 (10.3，14.8) 0.681 
S G R Q © iSymptom 41.3 (27.3,53.1)39.2 (24.8,51.5) 0.594 
(0-100) 
18.9 (7.5,33.3) 13.5(5.5，19.4) 0.138 
Activity 48.3 (30.7，65.0)41.0 (29.6,58.2) 0.286 
Total score 31.3 (20.2, 44.7)24.0(18.0,30.4) 0.107 
{ Mann-Whitney test ©： the higher score, the poor condition 
There was no difference between the two groups in physical assessment, exercise 
tolerance test ,and Quality of Life assessment at 48 weeks follow up. 
4.5 Results from baseline to second follow up within exercise group or within 
control group 
The changes from baseline to 12 weeks and 48 weeks in the exercise group or in 
the control group with respect to physical assessment, exercise tolerance, and quality 
of life assessment using paired t-test and non- parametric test are shown in table 4.5-a 
and table 4.5-b as below: 
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Table 4.5-a : Values and change from baseline in exercise group with respect to 
physical assessment, exercise tolerance, and quality of life 
Variable measurements 
baseline 12 weeks 48 weeks 
(n=43) (n=35) (n=32) 
Physical assessmentt 
PEFR(L/min) 1151(85) |179(92)# 1148(79) 
Sp02 rest(%) 94.4(2.9) 95.1(2.7) 95.0(3.0) 
FEVl(L) 0.57(0.22) 0.61(0.22) 0.57(0.22) 
FVC(L) 1.09(0.38) 1.15(0.35) 1.11(0.40) 
Quality of Life } 
A D L Performance score164(58,73) 169(61,80)# 165(55,76) 
GDS(0-15) © 5.1(2.8,7.0) 3.5(2.0,5.0)# 4.5(2.0,7.5) 
PGC(0-17) 11.6(8.8,14.0)12.6(11.0,15.0)^12.3(10.5,14.5) 
I symptom 54.3(42.1,68.9)^39.8(23.2,52.6)# 39.6(24.9,51.4)* 
S G R Q impact 33.2(14.7,52.6) 14.6(5.8,17.5)# 15.5(5.5,19.4)*^ 
(0-100) activity 51.9(32.7,68.2) 35.1(15.7,49.9)# 15.4(29.7,61.5) 
Total score 39.9(29.0,49.1) 24.3(15.5,34.9)# 26.4(18.1,31-1)* 
Exercise tolerance f 
6mwt(m) 1249.5(98.7) 1275.7(116.8) 1240.2(124.3) 
Stairs walking (steps) 60(41) 84(63)5 53(38) 
BicycleiMets 3.87(0.76) 4.22(1.17) 4.23(1.26) 
ergometiy 44(11) 51(14)# 46(!^ 
Duration(min) 2.3(1.2) 2.8(1.4)# 2.3(1.2) 
卞：paired t-test t： non-parametric test ©: the higher score, the poor condition 
#Coinpared with baseline p<0.05 *Compared with baseline p<0.05 
* • «. 
Table 4.5-b : Values and change from baseline in control group with respect to physical 
assessment, exercise tolerance, and quality of life 
Variable measurements 
baseline 12 weeks 48 weeks 
(n=32) (n=29) (n=23) 
Physical assessment 卞 
PEFR(L/min) 1160(70) .|152(71)# 1155(77) 
Sp02 rest(%) 94.0(4.2) 94.7(3.0) 94.5(3.3) 
FEVl(L) 0.65(0.29) 0.63(0.24) 0.65(0.31) 
FVC(L) 1.15(0.51) 1.19(0.46) 1.21(0.51) 
Quality of Life J 
A D L Performance score166(58,75) 165(53,78) 165(55,78)* 
GDS(0-15)© 4.1(2.0,6.0) 4.7(3.0,6.0)# 4.4(2.2,5.8)* 
PGC(0-17) 12.4(9.5,15.0) 12.3(10.5,14.8) 12.2(11.0,14.0)* 
I symptom 46.9(36.4,61.0) 49.8(35.9,65.5) 42.4(27.3,53.1)^ 
S G R Q © impact 26.4(9.3,42.6) 24.5(10.0,32.0) 21.3(7.5,33.3)""" 
(0-100) 
activity 40.9(16.1,70.6) 51.4(29.6,70.6)#49.4(48.3,65.0) 
Total score 31.6(19.1,41.8) 35.1(21.6,46.4)#31.7(20.2,44.7) 
Exercise tolerance f 
6mwt(m) 1247.3(116.5)|231.2(109.8)# 1215.8(113.8)* 
Stairs walking (steps) 57(39) 47(37)# 46(25)* 
BicycleiMets 6.89(3.02) 4.18(0.87) 3.95(0.86) 
ergometry Watt 62(38) 48(14) 44(11) 
Duration(min) 3.9(3.8) 2.5(1.5) 2.2(1.2) 
卞 paired t-test t： non-parametric test ©: the higher score, the poor condition 
#Compared with baseline p<0.05 *Compared with baseline p<0.05 
* • «. 
In the exercise group, there was significant improvement in PEFR, A D L 
Performance Score, GDS, S G R Q (symptom, impact, activity, and total score), stairs 
walking, and bicycle ergometry(watt, duration) from the baseline to 12 weeks, and the 
significant improvement maintained to 48 weeks in SGRQ(symptom, impact, and total 
score). 
In the control group, there was a significant decrease in PEFR, GDS, S G R Q 
(activity and total score), 6 M W T , and stairs walking from the baseline to 12 weeks, 
and there was also a significant decrease in A D L Performance Score, GDS, PGC, 
6 M W T , and stairs walking from the baseline to 48 weeks. 
Although there was no statistically significant improvement in six minutes 
walking test in the exercise group from the baseline to 12 weeks, the distance walked 
improved from 249.5(98.7)meters to 275.7(116.8)meters(increase of 10.5%), while 
that for the control group decreased from 247.3(110.7) meters to 
231.2(109.8)meters(decrease of 6.5%). 
* • «. 
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5.1 Short-term efficacy of pulmonary program 
5.1.1 pulmonary function 
There is little evidence that pulmonary rehabilitation can improve pulmonary 
function or arterial gases. Significant improvements in FEVl have only been reported 
in 4 of 34 pervious studies (Bach JR, 1996). Significant increase in F V C have been 
reported in 2 of 13 studies (Emery CF, 1991;Ries AL, 1988).Our study also showed 
small improvements in pulmonary function, such as PEFR, FEVl, FVC. Although 
PEFR increased by 17%, FEVl increased by 7%, and F V C increased by 6%, an 
increase of less than 15%-20% is generally not considered clinically significant. 
(Table 4.5a) 
5.1.2 Exercise tolerance 
In our study of the outcome of pulmonary rehabilitation，the major physiologic 
changes observed were improvements in exercise tolerance tests. The exercise 
endurance and workload increased significantly in the bicycle ergometry test 
following the 12 weeks' program. This is in accordance with the previous studies in a 
mixed group combined with C O P D and asthma patients after a 3 month out-patient 
rehabilitation program (Gosselink H A A M et al, 1990; Cambach W et al, 1997), and in 
patients with C O P D after an 8 week in-patient followed by a 16 week out-patient 
programme (Goldstein RS, et al, 1994). However, some studies that have measured 
* • «. 
gas exchange at rest and during exercise showed no change in these parameters despite 
the presence of improved exercise endurance.(Alpert JS, Bass H，et al. 1975). 
Therefore, the improvement in exercise endurance is to be accounted for by any 
improvement in lung function. It is possible that improve muscle strength maybe a 
factor. 
Timed walking tests can be used to indirectly measure exercise capacity 
following rehabilitation treatment. In our study, the substantial improvements in 6 
minute walking test in the exercise group (by 26.2 meters, a 10.5% increase) compared 
with decrease in the control group (by 16.1 meters, a 6.5% decrease) were observed, 
which approached the minimum clinically important difference(MCID) for the 6 
minute walking test (by 30 meters) ( Guyatt GH, et al, 1987). The term M C I D is 
defined as the smallest difference perceived by the average patient. An intervention for 
which the magnitude of the treatment effect equals or exceeds the M C I D should 
mandate a change in patient management, unless there are troublesome side effects or 
excessive cost (Jaeschke R, Singer J,1989). Actually, the previous studies that have 
used timed walking tests to evaluate the benefits of rehabilitation treatment have 
virtually all shown a clinically relevant improvement in the distance walked after 
treatment. For example, a 6% increase was noted in a controlled study of 28 patients 
compared with a 2 % decrease in control subjects. ( McGavin CR, et al. 1977)，and a 
* • «. 
42% increase was observed in one uncontrolled study of 24 patients undergoing 
supervised exercise for 3 month. (Tydeman DE, et al, 1984). 
In addition, there were significant improvements in the stairs walking test 
following our 12 weeks' program. To our knowledge, the test had not been used in 
previous studies. The test was chosen because it not only tested the endurance (as in 6 
minutes walking test), but the combination of strength and endurance. It is also more 
relevant in local context as most of the buildings in Hong Kong have either slopes or 
stairs, and it reflected the improvement in functional aspect. 
5.1.3 Other parameters 
The changes in parameters that we observed from our study include improve 
A D L performance , decline in measure the geriatric depression scale, and the St. 
George's Respiratory Questionnaire (Table 4.5a). These changes indicated that such a 
comprehensive pulmonary rehabilitation were of use to the patients in improving their 
quality of life. This is in accordance with the previous studies in a community-based 
pulmonary rehabilitation programme run by Cambach W (Cambach W et al, 1997) 
and a inpatient-based rehabilitation programme run by Goldstein R.( Goldstein RS, et 
al, 1994). 
* • «. 
There is some evidence that improvements in exercise tolerance may transfer to 
performance of activities of daily living and QOL.(Goldstein RS, 1994; Wijkstra 
PJ,1994). A vicious circle of inactivity in the C O P D patient was observed. 
Breathlessness on exertion results in relative inactivity with a consequent decline in 
"conditioning" of cardiac status and muscle tone. Exercise efficiency declines, 
resulting in decreased exercise tolerance by dyspnoea and tiredness. This in turn leads 
to a further decline in activity and the familiar pattern of decreasing social range. 
Cockcroft (Cockcroft, 1988) has pointed out that respiratory rehabilitation can result 
in a reversal of the stepwise process so that a relatively small increment in exercise 
endurance my, if it pushes the patient up a "step", produce a larger than anticipated 
increase in quality of life. 
Our study was a comprehensive pulmonary rehabilitation program, which 
involved the component of breathing retraining and coordinated breathing in activities 
of daily living task and symptom management besides exercise training. The patients 
may incorporated the teachings of the program into their daily activities. In addition, it 
was a group setting so that the patients can acquire the psychological support not only 
from the old age home staff and the author but also the other group members. 
* • «. 
5.2 Long-term efficacy of pulmonary program 
The long-term efficacy of pulmonary rehabilitation program was based on 
outcome measures at the 48 weeks follow up. Comparing the trend with time between 
the exercise group and the control group, the exercise group showed a trend towards 
improvement followed by decline on stopping the program, while the control group 
had a pattern of stepwise deterioration. Parameters representing pulmonary function, 
exercise tolerance, and quality of life in the exercise group showed no difference 
compared to the baseline, with the exception of the St. George's Respiratory 
Questionnaire (SGRQ). In agreement with the findings of Vale and co-worker (Vale F 
et al, 1993), in a group of C O P D patients, the overall C R D Q score, measured 11+/- 6 
months, after finishing the rehabilitation program, remained significantly greater than 
baseline scores. The present study shows that benefits in Q O L measured after 8 
months are retained more than benefits in exercise tolerance. It is uncertain whether 
the benefits in terms of exercise tolerance and Q O L will be maintained if the exercise 
programme were to continue for a longer period. 
An recently study run by Griffiths TL ( Griffiths TL，2000) including 200 patients 
with C O P D (average FEVl 39.7% predicted) undergoing 6 weeks of outpatient 
rehabilitation showed not only effectiveness in the short term(6 weeks), but also the 
long term (1 year) of walking ability improvement and health status improvements, 
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although the difference between the control and the rehabilitation group became 
smaller with time. This finding is different from our study, and also most previous 
studies (Vale F，1993; Wijkstra PJ，1995; Strijbos JH, 1996)，which all suggest a 
progressive loss of effect in the rehabilitation group. The programme used in the study 
by Griffiths et al was both intensive and interdisciplinary. The effort expended on 
teaching knowledge, coping strategies, and life skills, coupled with a rigorous 
exercise-training program, may explain the long term effectiveness demonstrated in 
their study. Furthermore, In Griffiths XL's study, the patients continued to attend the 
weekly patient-run exercise class and social meeting after the 6 weeks' outpatient PRP, 
perhaps accounting for the long-term effectiveness. 
Therefore marked improvements can occur in the respiratory patient during a 
short period of intensive pulmonary rehabilitation. Maintaining these improvements in 
the months and years that follow, however, is difficult. Mary (Mary, 1993) suggested 
that some form of continuing care and encouragement is usually required for the 
patient to maintain an exercise program, to maintain and update their knowledge of the 
disease, and to provide for psychosocial needs. H o w this may be achieved would 
depend on the health service structure in different countries. 
5.3 The characteristics of this pulmonary program 
* • «. 
An advantage of the study is simple. It can be performed easily in the old-old 
population, and is feasible even for the patients with mild cognitive impairment. Most 
of the patients learned and grasped the exercise skills within 6 weeks and it is possible 
for the programme to be continued in old age homes without supervision. However, 
the psychological and social support of being in a group may have played an important 
role in the patients' continuing interest. Simplicity is also an important factor in 
practicing such a program in the nursing home setting, where there is lack of 
specialized training equipment and professional manpower to coordinated the 
program. 
A potential concern on exercise training among elderly is its safety profile. In our 
study, there was no injury nor exercise induced hospital admission. The exercise 
training was under the supervision of at least one staff of nursing home, who cared for 
and monitored the patients during the course of exercise. The exercise intensity was 
initially assessed by the author and was designed to be symptom limited, and taken 
when medical conditions have stabilized. Patients were encouraged to participate at 
this comfortable level in the first two weeks, with subsequent increment biweekly 
according to their own maximum physical tolerance. In practice, the mean age of the 
exercise group is 81 years, two of the oldest patient being 92-year-old, and no side-
* • «. 
effects or injures were accounted. Therefore, it is safe enough in the frail old-old 
population. 
One of the characteristics of this study is the subjects' age. As we known, Hong 
Kong's population has been aging steadily. The older population, the more resources 
on the medical and social services is needed. H o w to achieve the good quality of 
long-term care for the elderly is still a problem. The study can be as a reference of 
pulmonary rehabilitation in the old-old population. Lacasse (Lacasse Y, et al, 1997) 
first undertook a meta-analysis of all randomized controlled trials in which pulmonary 
rehabilitation, including systemic exercise for at least four weeks, compared with the 
control patients. There were 14 studies from year 1977 to 1996 were summarized. The 
mean age of the 14 studies was from 61 to 73. None was estimate the effect of 
rehabilitation among patients 75 years of age or older. The mean age of our study is 81, 
which is the first one running such a program in the old-old population. It confirmed 
that old-old population would also benefit from pulmonary rehabilitation program. 
The study was also unique in its community based setting. The study was 
performed in nursing homes. In Lacasse's meta-analysis, 3 of 14 studies were at 
inpatient setting, 6 of 14 studies were at outpatient setting, 5 were at home-based 
setting. None was at a nursing home setting. As a domiciliary pulmonary rehabilitation 
program, it is partly different from home-based setting. For the latter, the support from 
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family member is important, which is not applicable to the elderly living alone or with 
an uncaring family. Furthermore, for the latter groups, there would be no 
communication between patients, so that mutual psychological support is not possible. 
In practice, the author found it important to facilitate exchange of ideas between 
subjects, so that they may leam inhaler techniques from one another, do morning 
exercise together, check on each other's breathing technique, and exercise training. 
Effectively a "Patient Self Help Group" was established in the nursing home and 
patients were empowered in the control of their symptoms and disease. 
Although the resource required to run such a program is not great, in practice, 
feasibility was still a problem. Three nursing homes out of 25 initially contacted in 
Shatin and Taipo districts refused to participate, and only 13 can afford at least one 
staff to supervise the exercise training. The feasibility ratio with respect to the number 
of residential homes willing to participate is 52%. From the point of view of 
participating subjects, only 75 out of 185 patients can participate in the study, 110 
having been excluded after screening. The main reasons for exclusion include 
FEVl/FVC >0.70 through spirometry test(45), cognitive impairment( 21), physical 
condition as bamer(15), other diagnosis(9), and unwillingness to participate(7),other 
medical condition as barrier (5), and death before intervention (1). The feasibility ratio 
for cases is 40.5% 
* • «. 
The study method was designed as a prospective controlled clinical trial but not a 
randomized controlled trial due to some unavoidable factors. Firstly, the influence in 
between each patient shouldn't be ignored. The patients are grouped together in 
nursing homes, which is different from other inpatient or community based setting. 
They knew each other quite well, and it would be difficult to carry out two different 
interventions in one nursing home, as compliance may decrease, there may be 
"contamination" of the control group. Secondly, the feasibility ratio in nursing homes 
is not high enough for randomization, and the sample size would be too small. This 
may introduce a bias into the study, in that only motivated subjects and homes 
participated, and the results will be applicable only for these patients. However, the 
nature of the treatment is such that it will only be relevant for cooperative and 
ambulant patients. The study showed the benefits in terms of improved exercise 
tolerance and Q O L for PRP in the residential home setting. Such programmes may be 
incorporated as part of the regular activities for C O P D patients in this setting. 
Further study to determine whether the continuation of such an exercise 
programme is of benefit in maintaining function, and the intensity and frequency of the 
exercise program, will be needed. 
* • «. 
Chapter Six: Conclusion 
To develop a Domiciliary Pulmonary Rehabilitation Program targeted at 
institutionalized elderly with C O P D living in Residential Homes is feasible and safe. 
There is substantial evidence that the short-term efficacy of PRP improving exercise 
tolerance and quality of life, but there is a trend of deteriorating Q O L and exercise 
tolerance on discontinuation of PRP. Not only community-living subjects, but also the 
frail elderly in residential homes can benefit from such programmes. 
* • «. 
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Appendix 





Name: . Scudy Number: 
Nursmg Home: ‘ 一 . 
HKID#： Date: . • 
(I) Demographic Factors . 
•Sex: • Male / • Female Age: 
t 
(II) Coexistfng Medical Coaditions (active or those that aSect fliiictioQal capacity) 
• Arthritis of Hand , 
• Lower Limb Arthritis • Fracture Hip • Others: 
• Cardiovascular Disease • 
• Hypertension d Others: ； 
• Neurological Disease -
• Cerebrovascular accident • Others: • 
/ 
• Diabetes mellitus _ 
• Endocrine disorder other than D M 
• GI and Hepatobiliary disorder _ 
• Others (specify): ： 
Cognitive Function: M M S E / 30 
(TEI) Chest Conditions 
m.I Smoking History . 
• Never smoker 
• Past smoker. Quitted for years ( number of cigarattes / day 
for years previously) 
• Current smoker. ( Number of cigarette / day for years) 
- IIL2 Known history of Tuberculosis • No / • Yes 
y 
丨 * — 
z 
Name: 如办 Number: 
Nursmg Home: 一 
• “ 
III. 3 Known history of allergy • Nil known 
• Pollen • chemical irritant • smoke / kerosene 
口 Others (specify): — — . 
1114 Symptomatalogy 
Duration of level ground walking: minutes 
Stairs climbing: steps / not applicable 
History of persistent cough with sputum for more more 3 months in past 2 consecutive . 
years? • No / • Yes 
Nocturai cough • No / • Yes 
Nocturai wheeze , • No / • Yes 
Snoring a N o / • Yes ’ . 
Number of Hospital admission from chest condition in past 1 year: ； 
nL5 Current respiratory conditioii: . 
Diagnostic labelling given (can be more than one): . 
• C O P D • Chronic asthma 
• Bronchiectasis . • Pulmonary fibrosis 、 
• Others (specify): ： 
Last prescription at 
.. • Shatin Hospital • P W H • LKS Medical ... 
, • C G A T • G O P D . • Chest Clinic 




” Scudy N u m b e r : . 
Name: 乂 
Nursing Home: z 
Nature: 
， … Prescrintion 
Oral B2-agorii5t • 
(eg. Terbutallne/ bricanyl, saibutamoI/venioILn) • No / • Yes 
Oral theophylline • N o / • Yes . 
^ _ • No / • Yes _ _ _ _ _ _ _ _ 
Pun 
If yes: • without volumadc • with vokimatic 
B2 agonist (saibutamol / ventolin) . • N o / • Yes 一 
SteroidCBecioforte / beclodde / puiinicort) • N o / • Yes • 
Ipratropium (atrovenr) •〜'。/• Yes 
Diuretics (eg. Fmsemide) • N o / • Yes 
, . • No / • Yes 
Nebulizsr solution 
Oxygen concentrator / portable oxygen • No / • ^ es , — 
rv Self of Skills/Quality Qf Life Measures - . 
rV.l A D L checklist by paaent (self rated) / 100 (see attached fonn) 
rV.2 Quality- of Life Questioriake 
"一 \ 
• Geriatric Depression Scale 丨。 ” 
• ？hiladebhia Ger:atnc Morale Scale H I , } (see attached ⑴二） 
• Sc George Chrome Respir-ccry Questiocaire } 
• Handicap Scale ‘ 
IV.3 Quesdocaire for cbsc-c-ve sleep aprxea syndrome ——.‘^^ 
.- (see artached f。〔） . 
rv.4 Skills in Iise of Puff-/- volirnadc . 
• see check List .. 
Name: ^�udy Number: 
Nursing Home: . _ 
t 一 ‘ 
rV Physiological / Functional Assessment 
rV.l Physiological parameters 
P E F R (L/min): Resting Sp〇2 at room air： % 
Body weight: • kg Height; cm 
Pre-Bronchodilator , Post Bronchodilator 
vihii % predicted Value . % predicted‘ 
T l V l 
T v c “ I 
“ ““(attach printout) 
VI Clinical Diagnosis of Chest Conditions . 
• C O P D without reversible obstructive element . 
• C O P D with reversible obstnicdve dement 
- • B r o n c h i e c t a s i s • Chronic Asthma • Pulmonary Fibrosis -
• Others (specif/): 
V n . R e c o m m e n d a d o a 
Potential Candidate for program • • No • Yes 
(If No, Reason for exclusion: 
• Unwilling to participate • Cognidvs iuipaLnneiit 
• Other medical condition as barrier (eg severe C H F / unstable angina) 
• Physical coQdition as barrier (eg. bilateral ':Ciee contracture) 
} 
• Others (spercify): • ‘ 
Revision of pufi"^ /- voiumatic lecrmique • No • Yes. . 
R e c o m m e n d e d for inhaiadoQ steroid • No Q 
R e c o m m e n d e d for LTOT ° N o • Yes • • 
f 
, Study Number: 
Name: • 乂 
Nursing Home: 
• * 
Vni Exercise Testing Date : 
V m i 6 M W T 
Total Distance travelled: , meter Fi〇2: L / min -
Sp02 Before Test: % Afer 亡est: % 
Dyspnoea Index Before Test: After test: 
% 
Vin.2 Stairs climbing . 腦 : — — ^ _ L / min 
Total number of steps climbed:. upsteps 
.sp02 ‘ Before Test: % After test: % 
Dyspnoea Index Before Test: After test: 
Yxn.3 Lower Limb ergometry 
Pi02 ： L /min, M E T S achieved: — 
— w S S n D i i i a t i o n ； ‘ ^ ^ ‘] ^ ^ O T " ^ 
Limiting factor ： 
• > 
• self stopped _ 
Reason of t.mimadon: • exertioaal dyspnoea • LL fatigue 
口 Others: 
• recommeaded to stop 
Reason of terminatioa: 口 asymptomadc，ye: Sp02 <37% 
•• • Cardiovascular event (axrhythmia, S3?>250, DBP>I 10，KR〉120). 
• Others: . 
(c： prp\dprpnh\basellna.doc) 
* • «. 
• . 
, Study Number: 
N a m e : 丄 
N u r s i n g H o m e : • 
. Skills in Usi'ng Puff 
2 A b l e CO perform conrecdy by patient alone 
1 A b l e CO perform carrscdy wich-prompcing . 
0 U n a b l e to perform correcdy despite prompting . 
If assessed to faile [n items marked with 〜patients will be caaghc co use pu^^-vciun^acic 
二orcprLdy (cwice) . Mark the results after skill taught. Receach【r railed. Ir raued co p【ck uo -
s〔m after caiighc far 3x, review far recommendation of oral cnedicacion. 




A. Use of iMDI without spacer 
1. remove M D I cap ‘ 
2. Shake M D I 
： 
3. Exhale before trigger — 
:——“ ~ r 
4 *Close lips tight around inhaler 
： —' ； 
5. Trigger once at a time ‘ • 
丨- _ » 
_ 6, *Inhale deeply while trigger . • 
7. *Hold breath far 5-10 second “ 
8. Take a break of 1 min before 2nd dose ^ 
9. Repeat steps 3-7 if required . _ 
10. Test when it b empty ； 
—"B, Spacer- if prescribed，or iffaHed to perform any 
skills marked * with for trWcs 
1.FoIIo>v5tep ;L-3 as MDI 
2. Insert L M D I to spacer ____ 
3. Valve movement ： 
4. Clean spacer “ . 
5. R e f u s e to u s e s p a c e r — 
‘,R.commcndncian: • suitable Co us. puff+Z- vclumacic by s^j.c： 們 
• need supc.-/ision / assistance rVorr^  scar: :o use purr ！- volumatic 
• for oral mcdicadon . 
(c:prp\dpra\puj]D2. dcc) ‘ . 
» . • y 
• ？ - X 
： 『 • . . 
：|. . . . . . • . 
} . • 
1 I 
. 




丨 . .病稀（九 1 1 /新弄 /香港茨适度）（邊 -縣 
. 二 九 誇 綱 度 ） （ 鹏 ） 
— ( 九 新 界 / 香 港 抚 連 度 ） （ 适 値 星 杖 ） 
丨 . . • （中心名字）（逢層核） ‘ 
： 野既名，講完之後.，誇命重裏一次〃 
； 3 ()依家，if一二皆产，芳會叫你專察番律我碧。 






•  q ,)埋樣係也野？（铅筆）（手赛），（2) _ 
. 二 』 姨 口 扉 ’ 師 - 字 一 齊 將 " 措 底 一 
半 ， 然 後 故 番 摄 兹 侄 授 上 面 ⑴ 
二 二 二 二 ： ) 一 人 〕 “ 今 曰 夭 、 . 
• 氣好好〕。m • • - ’ 
哩處有幅画’ I S 尔 照 佳 裝 妄 啦 二 a 分 . 
胸肺治療 经名• ： 
曰 常 生 后 囊 
( A D L Performance Score) 
/ i 
- f / -
二 1 T7 ' J ' 二 
w • / > ' J • 一 
, . . , / f ' • _ /•'Zjf — —W-丨丨• • 
5 - ？又；；：三；•"厂.」（二：广乂 ‘ 又另次，Uc—〈—二 
d -我能夠 S己‘但 ®受少 f ^象 5。 
3 -我资得链起天十分氣’至不多令不豕‘ 
2 -妄需5?人S我—起运丄 — 
1 - 有 人 S S ‘ ^ 
0 -未fSziS或不ffi要:S 
：•罢1敌.A坐者1不是、琪召笔；阮 .-
〜 — I 
二 二 坑二C： 1 
— ^ — ( 
-‘：：/-^：•^舍 . 
-r-- ； 
_ ‘ - • ‘ _ � “ • , � � • “ • - e r r 
^ '筑/兀 - i 
I -r：； —-- . - r c±r ：二圣 1 � . — 
V — , _ • . . . 一 一 〜 ‘ — — 
[ 牙 〒 二 丨 fe ： 
� , * �� • — — — I 
二^—； ‘“^乂^  / I 
一•^广.《-•：二。入 — — I 
；、 i � n i i f f ‘‘ • J 
. . . I �� / z 、 - • • • 11 - , 
「s—>^-:i、亡二品 f本巡般/：^藥/'：^多) i 
！ 某 二 八 ： 不 二 ‘ 乂 乂 ) ； 
I •.� - I —— i 
‘‘= I ； • 
--r-.r ' . • - p-C：- — =: ！ 
• ^ ― — � ： • • ， • . ； 1 4 • I . ； J 
厘 煮 食 煑 : Y / 煮 麵 ） . ！ - — — I 
：丨。.‘ 1 簡 重 家 務 R 法 G ^ / 秀 进 
‘ ‘ I I • I I 
i 第 二 . 这 / 。 、 六 , 一 j 
； 苍 i.义 . J 一 ； 
— ！ , j 二二 S 仁 / 三 三 i 1 
i ！ — J I =. ! " i 
'一 . ：~： I I 
I I r S 樓 梯 n � 
- 1 . I 
i . ^  1 ； 
!落一没 
i ；：丨〈二专•^弘 : 之 — ' -、 ^ ^；： ^ /斤字、、 I 
I I'Viii^ ^ 豕 、 —,二 ：—^, - ‘ — ‘ —— j — 1 
； I ' ^ n 1'宅 ^ ‘： I - 1 
vix 1 小 I . 一 ； j 
1 — ： 一, ； ： > ^ ― ^ — / 二;TZ 三 二 、 丨 I I . ， J , - ‘ , .1. — 一 ‘ ’ . ‘ • ！ � R — ~ -二 ~ — — I “ I _. • ‘ � I — • - F . — V — \ • I \ . — , -- / � 丨/]丨二 • ^ 麥 梦 . 一 《 八 ’ 一 — 一 ： i 
^ • f T 
• ：•'-• y - . I 
« 
去 人 F F L I I G ^ F ； ^ 表 R 卯 
- “ 歡 i 
> 
[.尔大致上滿考s.g你§己《生后？ t=‘f，s ( ) 
CN 済：S 
2.你係TO放{£应好多你老g動同埋興趣呢？ C ) 
k ty I� 
3. 你會写會覺得你考生g轻尝聊？ 写會 （ . ） 
4. 你會每會經常得经 ? 3 ？ ‘ • 辱 會 ’ （ ） •  ‘ 
. . 5 . 你 係 M i l 常 都 受 髓 薪 好 ？ . 一 驗 . （ ） 
• CH^ 
• 6. M 夸 有 D 唁 身 上 • 碎 會 ( ) 
. —— 
7 . 你 係 ^ # ^ ^ 受 薪 ? § 心 ？ . ( . ) 
. . 0 = ^ . 
5 . 你 係 藝 成 曰 都 受 莉 t ^ s r 雕 ？ ••() ； • • - 1 = ^ 
9 .你係 c s ^ a s s碌 M i f e多’ i s ^ ？ ^ ^ • ( ) 
1 0 ： 你 受 性 多 （ . ） 
• • 
11.哪！你而家椅，你受得閣唔弹[呀‘？ 得 . . . ( ) 
1 2 .你天 @得自己 m后？ . . . （ ） 
13.你覺唔变得自己充滿活力？ I I S ^ ( 
1 4 . 你 覺 唔 « 得 而 家 舒 逮 希 S ？ •、 ( 
• 1 5 .你 ^1 £ ^洛大部份人《生 « ^ ? _你？ J R J ^ ( 
..  總分: ( ) . • ‘ ‘ 
* • «. 
Name: . ^tudy Number: 
Nursing H o m e : — 
〔 f 分 Score ~ D ^ 
I 叫 Q ~ ~ 
[. Do chings keep getting worse as you get older^ No Yes 
事情是否一年比—竺差9 ： 
2. Do you have as much energy as you did last year? y e s No 
今年精力是否和上年一樣好9 
3. Do you reel lonely much? No Yes 
有沒有經常感到寂冥7 -
Do you see enough of your friends 8l relatives? y e s No 
與親戚朗友欽面足夠嗎？ ： 
5. Da lictie chings bother you. more this year? No Yes 
有沒有爲乂]^^1臓 . 
6. As you get older, do you feel less useful? No Yes 
有沒有惑受愈年老愈沒周？ 一 
7. Do you sometimes worry so much you can' t sleep? No Yes 
有沒有經常因憂心而失跟? -
S- As you get older, arc things better than expected? y e s No 
年紀大了，是否覺得辜惰比期望中好？ 
9.- Do you sometimes feci that life isn ' t worth living? N o Yes 
你 是 否 有 持 受 全 装 意 義 ？ 
10. Are you happy now as you were when you were younger? y^^ No 
你是否像年靑詩一樣快棻? -
11. Da you have a lot tobe sad about? No Yes 
是否許多事1育令保不開心? 
12. Are you afraid of aiot of things? N o Yes 
你是否對很多事到害怕 ? 
n . Do you gee angry aa rc ^ a n you used to? No Yes . 
你是否比以前更容易發怒? 
14. Is life hard for yoamos: of chc time-? No Yes 
一生中是否大部转間惑到生活艱诞？ 
15. Are you sacisfied wkh-your life codny? Yes No 
對 a己現時的生 $到滿宽哦 
15. Do you take ihtngsfcrd? No Yes 
苟沒有射4丨丨，^ •^很妄甚巧不! 
{7. Do you j^et uf)iic【osiiy? No Yes -
j^lk否很容Aj不丨j 口元4 




這I分卩二彳卷是希望可以E訪你至譯你浮：丢.约問題。 ‘‘ '二二-f -
. ‘ T•二二 || • 
f A “ • • 一 ‘ ‘ 一 - — 
！ • 
r — • _ �� 
身扮證號锡： ^ 三芒： 
I — • — • 
C tV： • 
1 在過去一年中，妄咳煮—密次數毕运是： 
. 口 ^ 星 薪 內 E 多 竺 的 曰 子 
• 一假星窮丨內有數天 严 




一 — . ^ - —_ 广 夺 二 一 
• 一個虽兒內巧夕^二二 ^ 
• 一恒星丨有鼓天 
• 一 适 星 窮 內 有 少 数 的 三 — 一 公 - 一 
• 只 是 三 杂 （ 约 ： 感 冒 ） 巧 众 
•壳全沒有疾 
— • 
•-J • ^ - - __ .1 
i i _ _ _ • 斤 巨 大 互 - 石 二 了 
f！ 一 巨 鼓天 
1 , _ y - - • - . - •？ 
n 一 個 星 妄 內 写 數 三 = 三 二 一 - 一 - 二 三 S 
rr 一 ==—.三，二巧.:.一_^ ‘―广：,€言、：二：?"書‘与广,二 
u 八 乏 二 5 巨 ' ： 〜 、 〜 心 二 ‘ 
=^rr in ^  -J=i. 
；___I 7 1： 二 •入二 ’。、乂广，-
” . L- -. 
4. - i j n： - ^ " — 一、 -〜一 
一,一 —雄 1 - • •^〜W __ 
-—� .rrr = � - — ,二 Z 广 - 、 
j I ：^^ —夕 — -
• 一 {：!星妄內有天 —_ -
(‘‘―i —, - ^ - - - —-
； 丨 -r .：：:-‘— 
— 一 一 — - , 一 一 三 乂 乂 一 




• 三 次 -







7你黌得你在過去一年 ^ ,平培一星期內有多少天你是覺得好的沒有被 





















(請答「是」或「否」惑「不適房」] 至 ^ 
,二 1 恩乂 
坐芸或睡覺的S寺候 • . . U • d 
— ... • 口 u 
法湊或更換衣服 _ _ p ‘ 
在街上丨曼步 ； 
行斜路 「 
行樓様 门 一 n 
行山 . r^ r r I二 
傲這動或玩遊戲〔如打•球、踪步、游泳） U U U 
4)你最近咳藏及氣騎的情祝是：（猜答「是」或「台」） 
咳嗽令我覺得病楚 •一 
咳藏令我覺得疲倦 . ’ ^ 厂 
當 我 說 _ 便 覺 ^ “ 
當我彎腰薛便覺得氣稳 -
咳歐及氣騎會影響我釣睡睡 一 一 ‘ ° ^ , 
我後容易覺得疲借（如洗澡、做簡單約冢務後）—• J 
5)你有否以下的感覺：（請答「是」或「否」） 
.，我黌得我咳敏或氣隐令我在公兵場合-得這— .口 .卩. 
.我氣瑞的問g對我的家人、朋友或鄰居做成不便 .口 • 
或令人討獻 门 
每次我覺得氣騎我便會有驚惶失措的感覺 ^ 
我感覺我不能控制我的氣隐情丨;^ _ ° P ‘ 
我覺得我的氣瑞是不會有新改善 ^ 
我覺得我的氣瑞令我變尿一個廢人 ° C 
運動對我來說是不安全的 一 〔 
我裝論做任何辜情都會覺得刀不從心 、 
6 )以下有一些於薬场的問題， m i M ^ ^何薬物 7請繼續回筌皇‘ 
I A : ( 請 答 「 是 」 或 「 否 」 ） _ 旦 ：^ 
藥物對我的幫动不大•’_二_ 口 ^ 
我在公共場所岳藥物特感到這遮 口 ^ 





广€ J g 厂〒M胃-) 
“ 是 ’ 否 不 適 M 
— — — 
我需賽尾f艮長釣薛間硫先或更^^服 一 .-一 口 ^ 
我不館钩g己法澡，家我需要很長的間工能核到 • 3 > 
；行®J比其他人慢，家我需5在步行f M 1，ft 一二 ° ° ^ 
我需賽周很長的持間做家務，家我需要，^間休思 • 纟： 
如杲我要上一層樓薛，我賓慢慢上或者丨休息 ° [ 
如杲我要趕路’我需要停下祙休息減运辰 ^ ^ P 
我 的 呼 吸 情 況 令 我 丨 故 一 些 輕 巧 約 ， 口 
行山、晨運、盒東西上'、跳蒡孰汀保-守二 
我 的 呼 吸 情 祝 令 我 做 • • U 
物件、.慢步踪（約每小持五公呈）、rh估4为 
旬 因 爲 你 的 呼 嘛 ， 你 有 什 麼 二 I ? 『 「 是 」 或 . 「 否 J 
請記著：你選澤r是」的話’是因為你呼吸的卩 =」題）是 否 
广 — 
我不能夠做這動或遊戲 Q • 
我不能夠出外參加一竖文娱活動 P • 
我不能夠出外買東酉 门 门• 




作爲參考，不后回答的）： . 、 〒 - 二 




, _ _ _ —— 
9)請你從以下選擇項你認爲最適合彩容你現在釣哼®情祝：. 
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